1981
Progress and challenges in the synthesis of sequence
controlled polysaccharides
Giulio Fittolani1,2, Theodore Tyrikos-Ergas1,2, Denisa Vargová1,
Manishkumar A. Chaube1 and Martina Delbianco*1
Review Open Access
Address: 1Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14476 Potsdam, Germany and 2Department of Chemistry and Biochemistry, Freie Universität Berlin, Arnimallee 22, 14195 Berlin, Germany
Email: Martina Delbianco* - martina.delbianco@mpikg.mpg.de
* Corresponding author
Keywords: enzymes; glycans; polysaccharides; synthesis; well-defined polymers
Beilstein J. Org. Chem. 2021, 17, 1981–2025. https://doi.org/10.3762/bjoc.17.129
Received: 21 May 2021 Accepted: 22 July 2021 Published: 05 August 2021
This article is part of the thematic issue "Polymer chemistry: fundamentals and applications".
Guest Editor: B. V. K. J. Schmidt
© 2021 Fittolani et al.; licensee Beilstein-Institut. License and terms: see end of document.
Abstract
The sequence, length and substitution of a polysaccharide influence its physical and biological properties. Thus, sequence con
trolled polysaccharides are important targets to establish structure–properties correlations. Polymerization techniques and enzy
matic methods have been optimized to obtain samples with well-defined substitution patterns and narrow molecular weight distribu
tion. Chemical synthesis has granted access to polysaccharides with full control over the length. Here, we review the progress
towards the synthesis of well-defined polysaccharides. For each class of polysaccharides, we discuss the available synthetic ap
proaches and their current limitations.
Introduction
Polysaccharides are an abundant class of natural polymers that
play important roles in the biosphere by structurally supporting
plants, providing energy to animals, and regulating a variety of
biological processes [1]. Their versatility and diversity result in
a wide range of properties exploited for commercial purposes.
Chemical modifications permit to broaden their applications
even further. Additionally, polysaccharides can be converted
into useful chemicals upon biodegradation [2,3], contributing to
the sustainable development of future materials.
Despite polysaccharides’ utility, there are limitations associated
with their exploitation. Extraction from natural sources is
laborious, low yielding, and provides heterogeneous mixtures
that hamper characterization, reproducibility, and quality
control. Small contaminations can heavily affect the
polysaccharides’ material and biological properties. This
issue became dramatic when contaminated batches of heparin
caused many deaths during the so called “heparin crisis” in
2008 [4].


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1982
Figure 1: Overview of the methods available for the synthesis of polysaccharides. For each method, advantages (green) and disadvantages (red) are highlighted. Polymerization techniques (A and B) generate mixtures of compounds with non-uniform distribution of molecular weight (MW). In contrast, chemical synthesis (C) produces well-defined polysaccharides, but it is time-consuming. Automated Glycan Assembly (AGA) increases the efficiency of chemical synthesis by automating cycles of coupling and deprotection on a solid support (D).
In addition, the heterogeneity of naturally sourced samples
poses a severe bottleneck to the molecular characterization
of polysaccharides that dwarfs in comparison to other
biomolecules like peptides and nucleic acids. Establishing struc
ture–property correlations is key to understanding polysaccha
rides’ function in nature and translate this knowledge into
tailor-made materials.
Synthesis (i.e., chemical, enzymatic, or through polymerization)
offers the opportunity to access polysaccharides with well
defined composition, length, and substitution. These com
pounds are ideal probes to study polysaccharides at the molecu
lar level and identify structure–property correlations. Access to
synthetic polysaccharides facilitated the correlation of chemical
structure with molecular conformations [5,6], intermolecular
interactions [7,8], and biological response [9]. Nevertheless, the
complexity and diversity of polysaccharides makes synthetic
processes extremely laborious and time consuming. Several
aspects are crucial to plan a successful polysaccharide synthe
sis. Properly designed starting materials and/or catalysts are re
quired to ensure regio- and stereocontrol during glycosidic bond
formation. Control over the polysaccharide length (degree of
polymerization, DP) and regioselective insertion of modifica
tions or branches are additional challenges. Three main ap
proaches are available (Figure 1): A) enzymatic polymerization
[10-17], B) chemical polymerization [18], C) chemical synthe
sis.
The use of enzymes has undeniable advantages because it offers
the possibility to use unprotected sugars as substrates and
guarantees remarkable control of the regio- and stereoselectivi
ty during glycosylation. Mono- or oligosaccharides bearing a
reactive leaving group (LG, e.g., phosphate, fluoride,
nucleotide) are polymerized by the enzyme to form the desired
polysaccharide (Figure 1A). Several classes of enzymes are
available, including hydrolases, phosphorylases, sucrases,
glycosyltransferases, and glycosynthases [19-22]. An excellent
overview of the enzymes available for polysaccharide synthesis
and their mode of action was recently published [11]. Despite
the numerous advantages of this approach, limited enzyme
availability as well as their high specificity narrowed the
substrate scope. Generally, the highly specific enzyme
reactive site tolerates only small modifications, hampering
the formation of unnatural polymers. Low glycosylation
yields and product hydrolysis represent additional hurdles
associated with enzymatic synthesis of polysaccharides [23].
With this approach, homopolymers are often obtained as
non-uniform samples, because the enzymes cannot distinguish
between acceptors with different lengths in the reaction mix
ture.


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1983
Chemical polymerization is often performed by ring-opening of
the respective anhydrosugar (Figure 1B) or polycondensation
reactions. This approach is highly valuable to generate long
chains in short time, allowing for the introduction of unnatural
modifications. However, the control over the length and substi
tution pattern remains poor. To ensure good regio- and stereose
lectivity, the starting material, often a polycyclic compound, has
to be designed with suitable protecting groups (PGs). These
structures can be quite challenging to prepare. Moreover, prob
lems can occur during the removal of the PGs, since partially
deprotected compounds can generate insoluble aggregates [24].
Incomplete deprotection and residual PGs can largely affect the
properties of the obtained polymer.
Chemical synthesis provides compounds with well-defined
length and substitution pattern (Figure 1C), but requires a sub
stantial synthetic effort. For this reason, only few examples of
long polysaccharides prepared by chemical synthesis are avail
able. Properly designed building blocks (BBs) are needed, often
prepared following numerous synthetic steps. In general, BBs
are equipped with a reactive anomeric LG to allow for glycosyl
ation and suitable PGs to ensure regio- and stereocontrol [25].
Even though, in most cases, BB preparation follows straightfor
ward protection/deprotection strategies, the low selectivity and
yield of certain transformations [26,27] can limit the scope of
this approach. The desired polysaccharide is generally assem
bled following a linear or a convergent approach. In the former,
the desired BBs are added sequentially to the growing polysac
charide chain via a series of glycosylation reactions. In contrast,
a convergent approach (also known as fragment coupling)
allows connecting pre-assembled oligosaccharide blocks.
To decrease the synthetic time required for the chemical synthe
sis of polysaccharides, automated techniques have been
developed [28-31]. Automated glycan assembly (AGA)
connects monosaccharide BBs on a solid support following
a linear approach (Figure 1D). Cycles of glycosylation and
selective deprotection are iteratively performed to access
the desired polysaccharide with full control over the length and
the monosaccharide sequence [32]. Upon completion of the
assembly, the desired product is released from the solid support
and subjected to global deprotection. Similar to chemical poly
merization, the removal of the PGs is a significant bottleneck.
Additionally, several transformations remain challenging due to
the poor reactivity or limited stereocontrol of certain BBs [33
37].
To overcome some limitations of the individual methods, a
combination of methods is sometimes exploited. A classic ex
ample is chemoenzymatic synthesis, in which synthetic BBs are
employed to direct the enzymatic synthesis towards the desired
polysaccharide target.
In this review, we discuss the recent efforts towards the synthe
sis of well-defined polysaccharides, with particular focus on
how to control the length and the substitution pattern. Each
section describes a class of polysaccharides based on a particu
lar monosaccharide backbone (Figure 2). For each class, we
discuss the specific challenges associated with their synthesis
and we highlight the methods that were developed to overcome
such bottlenecks. We aim to provide guidelines for the synthe
sis of a target polysaccharide, as well as to identify the
remaining bottlenecks associated with each class of polysaccha
rides. For this reason, the synthesis of polysaccharides based on
a highly heterogeneous backbone will not be discussed [38-40].
Such syntheses are specific to the single polysaccharide target
and only applicable to that particular sequence.
Each chapter focuses on recent literature describing the synthe
sis of oligo- and polysaccharides longer than hexasaccharides.
Shorter oligomers are discussed when they represent a key step
towards the synthesis of the corresponding polysaccharide.
Polymers based on a sugar backbone connected via glycosidic
linkages are analyzed, excluding glycopolymers and other
mimetics. Extraction methodologies or post-extraction modifi
cations are not discussed.
Review Glucose-based polysaccharides Cellulose
Cellulose is a polymer consisting of glucose units connected by
β(1–4) glycosidic bonds. It is mainly found in two allomorphs 
Cellulose I (natural) and Cellulose II (synthetic) – that differ in
the orientation of the individual chains and in the number of
hydrogen bonds in the crystalline structures [42,43]. In Cellu
lose I, the chains are oriented parallel, whereas in Cellulose II
antiparallel. Natural cellulose is produced by cellulose
synthases [44-46]. As the chain gets elongated, microfibrils are
formed. Such fibrils are the main structural components of the
plant cell-wall, together with hemicelluloses [47]. Because of
the high abundance and biodegradability [48-52], cellulosic ma
terials have found multiple industrial applications [53].
Synthesis and utilization, as well as a better understanding of
cellulose’s properties are hindered by its poor solubility in most
solvents. Relatively short oligomers with DPs of 6–10 tend to
aggregate and precipitate out of solution [54], making isolation
of pure samples troublesome. Much effort has been put to tune
the synthetic conditions and produce long and uniform polysac
charides. Solvent systems like DMAc/LiCl or quaternary am
monium electrolytes are able to dissolve cellulose and could
overcome the precipitation issues during synthesis [55,56];
however, these systems are not always compatible with reac
tion conditions [57]. The developments of synthetic cellulose


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1984
Figure 2: Overview of the classes of polysaccharides discussed in this review. Each section deals with polysaccharides built on the same monosaccharide backbone. Representation following the Symbol Nomenclature For Glycans (SNFG) [41].
until the year 2005 were discussed in a previous review [58],
therefore we will focus only on recent reports. A detailed
discussion on the synthesis of cellulose oligomers by enzy
matic depolymerization [59] and phosphorylase [60] can be
found elsewhere.
The first successful enzymatic synthesis of cellulose was re
ported by Kobayashi in 1991 [61]. Since then, a plethora of en
zymes [62] and substrates [63] were developed, aiming to
narrow the dispersion of molecular weight (MW), increase the
DP, or control the molecular organization of the resulting mate
rial (Scheme 1). Enzymatic polymerization of cellobiose fluo
ride 1 was achieved using a cellulase produced from Tricho
derma viride (Scheme 1A). The DP of the acetylated product
was shown to be at least 22. Using a purified version of this en
zyme, it was possible to obtain a synthetic analogue of Cellu
lose I [64].
A rough control of DPs (between 5 and 14) could be obtained
tuning the concentration of glucose (2a) or cellobiose (2b)
primer acceptor [65]. Polymerization conducted under macro
molecular crowding conditions using water-soluble polymers
produced hydrogels consisting of cellulose and gelatin networks
[54,66-69]. A study of the self-assembly of cellulose chains at
the active site of the enzyme suggested that diffusion of the
aggregated molecules and the monomers around the active
center dictates the DP that can be obtained by enzymatic poly
merization [70,71]. This could be the reason causing enzymatic
reactions to stop after a certain chain length, as the active site
becomes overcrowded. Thus, by modifying the reaction medi
um, a better control over the DP may be achieved.
Longer cellulose chains (DP > 100) were obtained using
DMAc/LiCl as reaction solvent and a cellulose surfactant com
plex, even though in low yields (2–5%). This approach circum


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1985
Scheme 1: Enzymatic and chemical polymerization approaches provide cellulose oligomers with a non-uniform distribution of MW. A) Cellulose oligomers can be synthesized using cellobiose fluoride 1 and cellulase. Other enzymes like cellodextrin phosphorylase (CDP) or cellobiose phosphorylase (CBP) use glucose (2a) or cellobiose (2b) primer respectively and glucose phosphate 3. B) Synthesis of cellulose by ROP from protected orthoester 4 promoted by Lewis acid (LA) or base (B).
vented the precipitation of the water-insoluble oligomers and
allowed for chain elongation [72,73]. This methodology was
improved employing a protic co-catalyst system to yield
DP > 120 in a 26% conversion [74]. Generally, an acid catalyst
would promote the hydrolysis of the glycosidic bond. In this
system, the SEE was hydrolytically inactive and the acid cataly
sis activated the C-1 at the reducing end efficiently to promote
chain-elongation.
Immobilized catalysis provided cellulose analogues with very
high crystallinity. A synthetic mutant enzyme of endoglucanase
II [75] was cross-linked by bis-nitrilotriacetic acid yielding
fibrous cellulose [76]. Cross-linked enzymes are believed to
arrange their catalytic core domains and promote the formation
of cellulose with high crystallinity. A similar principle was also
demonstrated on a self-assembled monolayer [77]. Mimicking
the natural cellulose synthases machinery can be foreseen to
provide synthetic Cellulose I.
Some enzymes offer the flexibility to produce modified cellu
lose structures. Cellulose oligomers with fluorine substitution at
C-2, C-3 or C-6 position were prepared by cellodextrin phos
phorylases [78]. Mono- or multi-fluorinated compounds were
obtained in good yields (30–47%) with average DPs ranging
from 9 to 15. The multifluorinated compound crystallized in a
new cellulose allomorph. AFM and TEM images confirmed the
formation of long platelets for monofluorinated compounds,
similar to those observed for cellulose [67,79], while the multi
fluorinated compound formed considerably shorter platelets.
Cellulose–xylan [80] and cellulose–chitin [81] hybrids were
also obtained upon enzymatic polymerization of the respective
dimers. An amino or azido functionality in the C-6 position
allows for further modifications, for example by click-chem
istry [82]. These results show that enzymatic methods can be
powerful approaches also to create unnatural polysaccharide
materials. Nevertheless, the inherent selectivity of the enzymes
limits these approaches to particular patterns and modifications.
To access a broader scope of cellulose modifications, chemical
polymerization is a more suitable option. Ring-opening poly
merization (ROP) of orthoesters 4 (Scheme 1B) is an estab
lished procedure for the synthesis of β(1–4)-glucopyranan struc
tures. The first chemical synthesis of stereoregular cellulose
was achieved by ROP of 3,6-dibenzyl-protected 4 catalyzed by
Ph3CBF4 [83]. The protected polymer 5 was obtained in 2 h in
62% yield and an average DP of 19.3. The benzyl (Bn) group
seems to be essential for the selective transformation [84].
Several derivatives were prepared in a similar fashion
(Scheme 1B), including the 6-deoxy [85], 13C-labelled [24],
ʟ-Glc [86], and ethyl/methyl analogues [87-89]. Depending on
the methyl/ethyl content, it was possible to tune the solubility of
the polymer in water. 6-O-Methyl- and 6-O-ethyl-celluloses
were poorly soluble in water, in contrast to heterogeneous poly
mers with an increased content of ethyl groups. Even though the


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1986
Scheme 2: AGA of a collection of cellulose analogues obtained using BBs 6–9. Specifically placed modifications prevented the formation of insoluble aggregates resulting in higher isolated yields. The AGA cycle includes coupling (NIS/TfOH), capping (Ac2O) and Fmoc deprotection (piperidine or Et3N).
methyl/ethyl content could be adjusted using different ratios of
the respective BBs, no control over the substitution pattern
could be achieved. Removal of the Bn PG posed a bottleneck,
requiring repeated treatments at high pressures and tempera
tures. Allyl groups provided a valid alternative and could be re
moved with palladium chloride at 60 °C in 4 hours [90].
Chemical synthesis grants full control over the polymer length,
avoiding non-uniform dispersions of MW obtained by polymer
ization. Polymers with virtually any possible pattern of modifi
cation can be prepared. Strategically introduced PGs can be
selectively removed to insert a branch or a chemical modifica
tion. However, to date, this approach has suffered dramatically
from the severe aggregation and insolubility of cellooligosac
charides, permitting to obtain only relatively short structures in
low yields. To overcome this issue, the products were con
verted and studied as their acetate analogues, as in the case of a
cellulose 20mer obtained with a convergent approach [91,92].
To date, the longest well-defined cellulose analogue produced
via chemical synthesis is a 12mer (13, Scheme 2), obtained in a
2% yield due to formation of insoluble aggregates during the
deprotection step, resulting in loss of product during purifica
tion [93]. 13 was obtained by AGA as part of a collection of
substituted compounds, obtained in much higher yields. Specifi
cally placed substituents including methyl, fluorine, and
carboxymethyl groups, prevented the formation of insoluble
aggregates by disrupting hydrogen-bond networks. Dramatic
differences in the conformation (e.g., radius of gyration and
glycosidic bond conformation) and aggregation behaviour (i.e.,
crystallinity and solubility) were observed for compounds with
the same degree but different pattern of substitution, under
scoring the importance of pure and well-defined polysaccha
rides for proper structure–property characterization. For exam
ple, compounds with an alternated methylation pattern resulted
in quasi-linear structures, whereas more bent geometries were
observed with a block wise arrangement of methyl groups. As
chemical synthesis offers high flexibility in terms of manipula
tion, non-carbohydrate moieties can be exploited to guide the
geometry of the resulting compounds. β(1–4)-Linked glucose
chains were connected parallel via an anthraquinone moiety to
give synthetic Cellulose I [94].
Overall, enzymatic synthesis is an established procedure to
obtain non-uniform cellulose oligo- and polysaccharides. Some
success was achieved using additives and molecular crowding
conditions; however, this approach remains limited by product
insolubility and enzyme flexibility. ROP allowed for the intro
duction of modifications in the structure, thus providing a first
step towards structure–properties correlations. Yet, the substitu
tion pattern remains random. Cellulose analogues were ob
tained with full control over the length and substitution pattern
by chemical synthesis, albeit in low yields. Selective disruption
of intra- and intermolecular hydrogen bonds suggested that
modifications can be designed to prevent precipitation and
guide cellulose assembly.
Xyloglucans
Xyloglucans (XGs) are based on a β(1–4)-Glc backbone deco
rated with xylopyranose branches, which can be further substi
tuted at the C-2 position by a β-linked galactose or a α-ʟ-fucose


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1987
Figure 3: Chemical structure of the different branches G, X, L, F commonly found in XGs. Names are given following the established nomenclature [100].
Scheme 3: AGA of XG analogues with defined side chains. The AGA cycle includes coupling (TMSOTf), Fmoc deprotection (Et3N), PMB deprotection (DDQ) and Lev deprotection (hydrazine).
unit (Figure 3). XGs are abundant components of the plant cell
wall, where they are believed to interact with cellulose
promoting the integrity of the plant wall [95]. However, a recent
study suggested that XGs are not essential for the creation of
the cellulose network [96].
The complexity and diversity of XGs hinder isolation from
natural sources and complicates their description. A significant
effort was put towards the development of enzymes for selec
tive introduction of the side chains [97,98]. A detailed overview
of the enzymatic strategies to generate artificial plant cell wall
polymers was recently published [11,99]. Here, we describe the
methods available to access well-defined XG oligo- and poly
saccharides.
The first solution phase synthesis of a nonasaccharide repeating
unit was realized using a convergent approach [101]. The
process was later simplified using AGA and several XG oligo
saccharides were prepared [102]. Representative examples are
19 and 20 (Scheme 3) [103], as well as the galactose-contain
ing compounds 21 and 22 [104]. These compounds permitted to
study XG recognition by plant cell-wall antibodies. To avoid
performing the challenging 1,2-cis glycosylation that would
generate a mixture of anomers in AGA, the α(1–6) linkage be
tween glucose and xylose was pre-installed in the disaccharide
BB 16 (Scheme 3, highlighted in red) [104]. The orthogonal
levulinoyl (Lev) and p-methoxybenzyl (PMB) PGs could be
selectively cleaved to allow for chain elongation and for intro
duction of the Gal unit at the C-2 of the xylopyranose, respec
tively.
An alternative approach utilized natural sourced XLLG tetrasac
charide, which was obtained from tamarind seed XG via enzy
matic digestion. This compound was then chemically trans
formed to the corresponding glycosyl donors (4-methoxy
phenyl- or fluoro-glycoside) to chemoenzymatically produce
complex XGs. Compounds with different substitution patterns
were obtained using a glycosynthase from Humicola insolens
[105,106]. This approach produced polysaccharides with con
trolled substitution, but no control over the length [107].


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1988
Figure 4: Synthetic strategies and issues associated to the formation of the β(1–3) linkage.
Similarly, XG fragments prepared by enzymatic degradation of
XGs were converted to the fluoride donors and used in the
subsequent glycosynthase-catalyzed transformations. (XXXG)3,
(XLLG)3, and XXXG-GGGG-XXXG were prepared to study
interactions with bacterial microcrystalline cellulose [108]. The
glycosyl fluoride donors were also polymerized to give
(XXXG)n and (XLLG)n with MW up to 12000 [109]. The syn
thesis of the highly branched (XLFG)n polysaccharides re
quired the additional fucosyltransferase AtFUT1 to introduce
the fucose residues [110].
Even though the complexity of plant polysaccharides hinders
their synthesis, these compounds are highly desirable to dissect
the different interactions taking place in the plant cell-wall.
Recognition of the branched oligomers by glycosynthases
proved to be limited and more enzymes are needed to broaden
applications and generate uniform polymers. Chemoenzymatic
methods provided XG oligo- and polymers, but are laborious,
requiring several synthetic steps for the synthesis of the
glycosyl donors.
β(1–3)-Glucans
β(1–3)-Glucans, linear or with β(1–6) appendances, are present
in the cell-wall of fungi and yeasts, and are major polysaccha
rides in brown seaweeds (laminarins) [111]. Due to their
immunostimulating, antibacterial and antitumor activities, linear
and branched β(1–3)-glucans have become interesting synthetic
targets. Since several reports highlighted the correlation be
tween chain length and biological activity, significant effort has
been put to chemically synthesize β(1–3)-glucans with well
defined lengths.
In contrast to β(1–4)-glucans (i.e., cellulose), β(1–3)-glucans
with a DP up to 20 can be dissolved in water [112], simplifying
the synthetic process. Several oligosaccharides have been pre
pared to identify the best PG pattern ensuring a proper balance
between BB reactivity, stereoselectivity, and simplicity of
deprotection [113-125]. Ester groups are commonly employed
at C-2 position to ensure anchimeric assistance during glycosyl
ation (Figure 4). However, the O-2 acyl group on the glycosyl
acceptor hinders the 3-O-glycosylation sterically and electroni
cally [126]. The decreased nucleophilicity of the C-3 hydroxy
acceptor could lead to poor stereoselectivity [127]. This issue
becomes even more dramatic when 2,4-di-O-acyl groups are
present, sometimes leading to exclusive formation of α-anomers
[128,129]. PGs like 2-O-ADMB (4-acetoxy-2,2-dimethylbu
tanoate) [130] or 2,2’-O-benzylidene [131] were introduced to
solve this issue. Several reports highlighted the importance of
the 4,6-O-benzylidene group on the glycosyl donor and the
acceptor for the stereoselective formation of the β(1–3) linkage
(Figure 4) [132].
Interestingly, oligomers bearing several 4,6-O-benzylidene
groups show anomalously small coupling constants for some of
the C-1 hydrogens. NMR [133] and X-ray [134] studies
revealed that, for some residues, the 4,6-O-benzylidene group
stabilizes a boat conformation (1,4B or B2,5), in contrast to the
standard chair (4C1). This unexpected conformation did not
affect the stereoselectivity of the glycosylation, permitting the
preparation of linear β(1–3)-glucans of different lengths (6mer,
8mer, 10mer and 12mer) following a convergent preactivation
based iterative strategy [135]. These compounds were subse
quently conjugated to keyhole limpet hemocyanin, revealing
that the length of the glucans affected the immunogenic proper
ties. A pre-activation-based iterative one-pot glycosylation
method was also employed to access different branched struc
tures having β(1–3)- and β(1–6)-linked Glc appendances on a
β(1–3) backbone [136].
To date, the longer β(1–3)-glucans [137,138] were obtained
using a 2-O-acylated donor, to ensure β-selectivity, followed by
deacylation and use of the resulting 2,3-diol as acceptor in the
following glycosylation [131]. A regioselective glycosylation
strategy was developed to obtain a collection of linear glucans


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1989
Scheme 4: Convergent synthesis of β(1–3)-glucans using a regioselective glycosylation strategy.
(8mer to 16mer) (Scheme 4), as well as a branched 9mer and
17mer [137,138]. A similar strategy based on the regioselective
glycosylation of a 2,3-diol 4,6-O-benzylidene acceptor
permitted to access various β(1–3)-glucans, ranging from trimer
to 13mer [126]. Regioselectivity was also achieved using a
gold-catalyzed glycosylation, to give a linear β(1–3)-linked
11mer and a branched 14mer in a convergent manner [139].
Collection of linear as well as branched β(1–3)-glucans with
defined lengths could be prepared by AGA [140-142]. The poor
nucleophilicity of the C-3 hydroxy group on the glycosyl
acceptor required the use of more reactive glycosyl phosphate
donors and, in some cases, a double glycosylation cycle
[118,143].
Longer structures, albeit with no control over the DP, could be
prepared via chemoenzymatic polymerization of α-lami
naribiosyl fluoride donors catalyzed by the mutated barley
β(1–3)-glucanase [144,145]. Linear β(1–3)-glucans with DP of
30–40 appeared as lamellar, hexagonal crystals. Electron and
X-ray diffraction studies revealed that long β(1–3)-glucan struc
tures adopt a parallel, triple helical structures [146]. A
glycosynthase derived from Bacillus licheniformis could poly
merize glycosyl fluoride donors to prepare artificial mixed
linkage β-glucans with an average molecular mass of
10–15 kDa [147].
The better solubility of β(1–3)-glucans, compared to the β(1–4)
analogues, has permitted the chemical or enzymatic synthesis of
long polysaccharides. Still, the poor nucleophilicity of the
hydroxy group at C-3, in the presence of a C-2 ester PG, could
decrease the efficiency of chemical synthesis. Hence, there is
scope for new strategies to provide anchimeric assistance, with
out affecting the nucleophilicity of the hydroxy group at C-3.
β(1–6)-Glucans
The formation of the β(1–6)-glycosidic bond poses less synthe
tic challenges than the β(1–3) bond. The primary C-6 hydroxy
group is more nucleophilic than the secondary hydroxy group at
C-3 and β-selectivity is easily achieved with the help of


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1990
Scheme 5: DMF-mediated 1,2-cis glycosylation. A) General mechanism and B) examples of α-glucans prepared using this approach.
anchimeric assistance provided by a 2-O-acyl functionality.
Despite these advantages, the synthesis of β(1–6)-Glc polysac
charides appears only in few reports [148,149], with short
oligomers being prepared mainly to prove new methodologies
[31,150-155].
The synthesis of structures longer than hexasaccharides suffered
from poor solubility during the deprotection step, likely due to
the formation of aggregates resulting from particular secondary
structures adopted by the partially protected intermediates
[156]. The replacement of a single Glc unit with a Man unit was
sufficient to disrupt this secondary structure and significantly
increased the isolated yield of the final compounds. Molecular
dynamic (MD) simulations predicted a compact helical confor
mation for the fully deprotected compound, confirmed by NMR
studies on a collection of 13C-labelled hexamers [157]. Similar
issues during deprotections were not observed when the β(1–6)
backbone was substituted with β(1–3) branches [158-166] and
long oligomers could be synthesized on solid support [157,166]
or in solution phase using block coupling [165].
α-Glucans
In contrast to the relatively simple formation of a 1,2-trans
glycosidic bond using participating group at C-2, the construc
tion of 1,2-cis glycosidic bonds is a long-standing challenge in
the field of glycochemistry [167]. The formation of 1,2-cis Glc
linkages is particularly relevant, as α(1–4)-glucans form the
backbone of starch, with the linear amylose and the branched
amylopectin, and α(1–3)-glucans are related to fungal patho
genicity in plants [168]. Only few options can aid the stereose
lective construction of 1,2-cis glycosidic bonds. In general,
stereocontrol can be obtained either by fine tuning of PGs at
C-3, C-4 or C-6 positions, or by making use of participating sol
vents [37,167]. 3-O-acyl and 6-O-acyl groups are commonly
employed to remotely participate in the glycosylation and
promote α-selectivity [169,170]. This strategy permitted to
prepare oligosaccharides having multiple α-glycosidic linkages
by AGA [171].
Additional strategies include the dehydrative glycosylation of
glucosyl hemiacetal [172] or the halide-catalyzed in situ
anomerization of glucosyl iodide donors that yielded α(1–6)
hexaglucans [173]. The halide-catalyzed in situ anomerization
approach was efficient in solid phase as well as in solution
phase synthesis. The participating (S)-(phenylthiomethyl)
benzyl chiral auxiliary at the C-2 position of the glucosyl donor
permitted the solid phase synthesis of a branched pentaglucan
having a α(1–3) branch on an α(1–6) backbone [174]. Boron
mediated aglycon delivery (BMAD) with the use of a diboron
catalyst allowed for regio-, as well as stereoselective glycosyla
tion to achieve an α(1-3)-pentaglucoside [175]. Regioselective
1,2-cis-glycosylation could also be achieved by boron-cata
lyzed coupling via a SNi-type mechanism [176]. Hydrogen
bond-mediated aglycon delivery (HAD) with the aid of a 4-O
picoloyl (Pico) group offered an interesting method to achieve
multiple α-glucosidic linkages. However, the efficacy of the
HAD diminished with the increased bulk of the glycosyl
acceptor [177].
In general, even though several elegant approaches were re
ported, the construction of multiple α-linkages remains chal
lenging, in particular with the increasing size of the acceptor.
The nucleophilic additive glycosylation-based approach
(Scheme 5A) offers the opportunity to install multiple 1,2-cis
glycosidic bonds by converting the glycosyl donor 30 into a less
reactive adduct 31. DMF-mediated glycosylations permitted
access to long structures based on multiple α(1–4) linkages 33
and 34 [178] and α(1–3) linkages 35 [179] (Scheme 5B). The
short oligosaccharide 36 having α(1–2) linkages was also pre
pared, however, in this case, the stereoselectivity diminished


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1991
Scheme 6: Synergistic glycosylation strategy employing a nucleophilic modulation strategy (TMSI and Ph3PO) in combination with the O-6-Lev remote anchimeric assistance. A) General glycosylation mechanism. B) Synthesis of linear α(1–6)-glucan 11mer and 30mer. C) AGA of starch and glycogen oligo- and polysaccharides. The AGA cycle includes coupling (NIS/TfOH), capping (Ac2O), Fmoc deprotection (Et3N), and Lev deprotection (hydrazine).
with the increasing length of the oligosaccharide, possibly due
to steric hindrance [180].
The nucleophilic modulation strategy in combination with the
O-6-Lev remote anchimeric assistance could further improve
the stereoselectivity of the 1,2-cis glycosylations, leading to the
synthesis of long linear α-glucans 43 (11mer and 30mer) having
multiple 1,2-cis glycosidic linkages (Scheme 6A and 6B) [181].
The remote anchimeric assistance from ester groups at C-3 and
C-6 on thioglucoside BBs 44 and 45 permitted the AGA of
linear 46a,b and branched 47–49 glucans with multiple 1,2-cis
linkages (Scheme 6C) [182].
To avoid the chemical formation of this challenging bond,
natural compounds containing 1,2-cis linkages could be
exploited. α-, β- and γ-cyclodextrins offered a good starting ma
terial to prepare stereoselectively a 6-O-methylated α(1–4)
glucopolysaccharides consisting of 6–20 monomer units
[183,184]. As alternative, stereoselectivity can be achieved with
enzymes. Glucan phosphorylase is commonly employed to
produce linear amylose polysaccharides with the desired aver
age MW by changing the glucose monophosphate/amylose
primer ratio [185]. This approach permitted the preparation of
amylose with narrow MW distribution, amylose hybrids, and
amylose-functionalized materials [186]. Linear and branched
oligosaccharides with mixed α(1–3) and α(1–4) linkages were
synthesized using a glucansucrase from Lactobacillus reuteri
[187,188].
Even though several chemical methods are available for the for
mation of 1,2-cis linkages, only few are unaffected by the in
creasing size of the target molecule. The recently published
synergistic approach that combines remote anchimeric assis
tance and nucleophilic modulation permitted access to long
linear α-glucans [181]. The implementation of a similar strategy
in AGA has already shown promising results [182] and could
fuel the production of well-defined polysaccharides based on
multiple 1,2-cis-glycosidic linkages.
Xylose-based polysaccharides
Xylans are abundant polysaccharides mainly found in plants or
in mammalian cells as proteoglycans [189,190]. They partici
pate in the formation of the cell-wall by interacting with cellu
lose microfibrils [191], however, these interactions lack a mo


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1992
Scheme 7: Different approaches to produce xylans. A) Polymerization techniques including ROP, and B) enzymatic polymerization yielded nonuniform homopolymers. C) Chemical synthesis following a convergent approach provided short oligomers with control over DP.
lecular description [192]. Some evidences suggest that the
xylan–cellulose interaction depends on the xylan substitution
pattern [193].
Natural xylans contain β(1–4), β(1–3) or a combination of
β(1–4)- and β(1–3)-linked β-ᴅ-xylopyranosyl units. Rarely,
α(1–3) glycosidic linkages are present [194]. These backbones
are often partially acetylated or appended with sugar side
chains, mainly ʟ-arabinose, fucose, galactose and 4-O-methyl
glucuronic acid [195]. In general, low substituted xylans are
forming insoluble aggregates, whereas heavily substituted
xylans are highly soluble in water [196,197]. Minor changes to
the xylan structure can dramatically affect their crystallinity and
solubility [198], highlighting the importance of obtaining well
defined samples.
Cationic ROP of anhydrosugars was the pioneering approach
for the preparation of synthetic, unnatural xylans. Polyxylofu
rans with (1–5) and (3–5) linkages were described [199,200]. In
most cases, non-uniform polysaccharides were obtained, as in
the case of α(1–5)-xylans, prepared in up to 93% yields and DP
between 45 to 477 (Scheme 7A) [201]. Enzymatic polymeriza
tion is generally performed using glycosyl fluorides as sub
strates, which are structurally related to the natural glycosyl en
zyme intermediate [202]. β-Xylobiosyl fluoride donors, selec
tively recognized by the cellulase from Trichoderma viride,
afforded xylans containing exclusively β(1–4) linkages in 72%
yield [203]. Compounds with DP higher than 23 constituted the
insoluble fraction (37% yield) (Scheme 7B). The combination
of XynB2-catalyzed dimerization of α-ᴅ-xylopyranosyl fluoride
and subsequent polymerization by XynA helped to overcome
the bottleneck of poor substrate-recognition of longer oligosac
charides by glycosynthases [204]. Still, the polymer was ob
tained with a wide range of DP between 6–100. Shorter Xyl
chains with up to 12 units were reported using a retaining
xylanase from Cellulomonas fimi [202].
Well-defined xylan oligosaccharides were obtained by chemi
cal synthesis following convergent or sequential glycosylation
approaches. These well-defined xylans allowed establishing
correlations between the substitution pattern, length, and macro
scopic properties (i.e., crystallinity, solubility, interactions with
other polysaccharides). To date, the longest xylans reported are
10mers [205], although there is in principle no reason hindering
the synthesis of longer structures. A convergent approach is
often employed to avoid tedious purification of unreacted
acceptors from the products, resulting from incomplete glyco
sylation. Peracetylated thioglycoside donors 52 were reacted
with 4-methylbenzoylated (MBz) acceptors 53, following NIS/
AgOTf activation (Scheme 7C). Upon global deprotection, a
collection of well-defined oligoxylans with 4–10 monosaccha
ride units was obtained [205]. A convergent approach was also
employed to prepare a β(1–3)-Xyl hexamer, an analogue of
xylans found in algae cell-walls [206]. TMSOTf promoted the
glycosylation of the Bz-protected disaccharide acceptor with the
Bz-protected tetrasaccharide trichloroacetimidate donor. Al
though not yet reported, the authors suggested that this method
can be extended to the synthesis of longer oligomers in a gram
scale.
To avoid purifications after each glycosylation step, oligoxy
lans were produced by AGA on solid support (Scheme 8A)
[207,208]. The iterative addition of monosaccharide BBs and
the use of orthogonal PGs permitted to control the length and
pattern of substitution. A collection of linear β(1–4)-ᴅ-xylan
chains and with α(1–3)-ʟ-arabinofuranosyl branches was
quickly assembled to identify the binding epitopes of mono
clonal antibodies. These oligomers, together with other well
defined analogues obtained by chemoenzymatic synthesis, were
converted to the respective glycosyl fluoride and used for enzy
matic polymerization catalyzed by XynAE265G (Scheme 8B)
[7]. This approach generated polymers 62a–g with well-defined
substitution patterns. Differences in solubility were observed for


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1993
Scheme 8: A) Synthesis of arabinofuranosyl-decorated xylan oligosaccharides using AGA. Representative compounds are reported. The AGA cycle includes coupling (NIS/TfOH for thioglycosides and TMSOTf for glycosyl phosphates), Fmoc deprotection (Et3N) and Nap deprotection (DDQ). Azmb = 2-(azidomethyl)benzoyl. B) Chemoenzymatic synthesis of arabinofuranosyl-decorated xylan polymers with well-defined substitution patterns.
certain patterns, affecting the efficiency of polymerization and
the DPs of the resulting polymers. Linear xylan precipitated
with a MW of 9.2 kDa. Arabinofuranosyl xylans substituted at
the C-2 or C-3 position of every third residue, formed crys
talline aggregates. The authors speculated that a threefold
helical screw conformation might enable the regular interaction
of individual chains. The arabinose pattern also played a role in
the interaction with cellulose, with the crystalline compound
62c that did not adsorb to cellulose, in contrast to 62b, which
adsorbed irreversibly. The high adsorption of 62b was associat
ed with its twofold helical screw conformation, only accessible
with this substitution pattern.
Overall, chemical and enzymatic polymerization are faster than
chemical synthesis, however, non-uniform xylans are always
generated. The chemoenzymatic approach permitted to prepare,
for the first time, arabinose-substituted polymers with a defined
substitution pattern. Although still lacking control over the
polymer length, these compounds underscored the importance
of well-defined polysaccharides to understand the microscopic
properties of natural xylans and fuel advancements in plant cell
wall biology [102].
Glucosamine-based polysaccharides Chitin and chitosan
Chitin is a linear polysaccharide composed of β(1–4)-linked
2-acetamido-2-deoxy-ᴅ-glucopyranose (GlcNAc) repeating
units, which mainly exists in the exoskeleton of crustaceans and
insects, as well as in the cell-wall of fungi [209,210]. Chitosan,
its partially N-deacetylated analogue, has vast industrial appli
cations in coating materials, cosmetics and pharmaceuticals
[211]. Owing to their superior biological and mechanical prop
erties, chitin and chitosan are used in fibers, gels, sponges,
films, beads, and nanoparticles [212]. Tunable stiffness, solu
bility, and transparency can be obtained by tuning of the DP and
fraction of acetylation (FA).
Chitooligosaccharides (COS: β(1–4)-linked oligomers of
GlcNAc and/or GlcN) have gained popularity due to their
exceptional antimicrobial, antitumor, and immune modulatory
activities [29,213-217]. Methods to obtain well-defined COS
with controlled size and substitution pattern are highly desir
able, because DP and FA affect the physicochemical properties
of the COS [218,219]. A size-dependent immune recognition
was verified in plant chitin receptors as well as in toll-like re


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1994
Scheme 9: Chemoenzymatic synthesis of COS utilizing a lysozyme-catalyzed transglycosylation reaction followed by the deprotection of N-chloroacetate.
ceptors (TLR2) [220]. Moreover, the PA can tune the biologi
cal activity, as demonstrated using partially acetylated COS ob
tained by enzymatic degradation of chitosan promoted by
hydrolases [221].
Chemical degradation of chitin promoted by acid treatment
[222-228] or using chitinases and chitosanases [229-231] gener
ates mixtures of short COS, which requires tedious purification
steps. Furthermore, degradation of natural chitin often lacks
proper control over the pattern of acetylation (PA). Acetolysis
also often leads to heterogeneous mixtures [232-235]. A con
trolled acetolysis of chitin, followed by the one-pot trans-N
trifluoroacetylation of peracetylated chitooligomers, could effi
ciently generate 1,2-(2-trifluoromethyloxazoline) donors. These
reactive compounds were employed to construct different
length COS, from dimer to hexamer [236].
Synthetic COS were prepared following chemical or enzymatic
polymerization, albeit with poor control over size and substitu
tion pattern. Classical methods include chitinase-catalyzed
assembly via ring-opening polyaddition of N,N’-diacetylchito
biose oxazoline derivatives [237-239] or self-condensation of
N-phthalimide protected thioglycoside [240]. Enzymatic poly
merization promoted by hydrolases is an interesting option to
produce long COS from shorter oligomers [241]. After cleaving
the glycosidic linkage, the enzyme remains attached to the new
reducing end of the oligomer, releasing the cleaved part. Subse
quently, the oligomer is transferred to another COS acceptor,
forming a new glycosidic bond [216]. Various enzymes have
been successfully employed, including β-N-acetyl
hexosaminidase [242], lysozyme (Scheme 9) [243], and endo
chitinase [244-246]. With these approaches, structures with a
DP up to 13 could be accessed. Genetically engineered transgly
cosylating hydrolases were employed to polymerize chemically
activated oligosaccharide substrates [216]. These chemoenzy
matic approaches are often based on glycosynthase-type GH18
or GH19 chitinases and produce mixture of COS with different
lengths [237,243,247-250].
Chemical synthesis offers the possibility to generate well
defined COS, but it is to date underexploited. The poor reactivi
ty of the C-4 hydroxy group of the glucosamine BB, and the
need of orthogonal PGs on the nitrogen atom to control the PA
are the main bottlenecks [251]. The β-directing N-phthaloyl
(N-Phth) PG was installed in trichloroacetimidate donors to
synthesize fully deacetylated COS up to 12mer. After each
glycosylation step, the 4-methoxyphenyl group at the anomeric
position was oxidatively removed and the resulting hemiacetal
was transformed into the trichloroacetimidate glycosyl donor
for the next glycosylation step [252]. An orthogonal glycosyla
tion strategy was developed to alternately stitch N-Phth-pro
tected thioglycoside donors and N-Phth-protected fluoride
donors to obtain COS up to 7mer (Scheme 10) [253]. Similarly,
trichloroacetimidate and thioglycoside donors permitted the
synthesis of short COS [254]. Upon assembly, the N-Phth PGs
were removed with hydrazine under reflux and the free amino
groups were acetylated to obtain the fully N-acetylated COS
[255].
Control over the pattern of N-acetylation was for the first time
achieved using two monosaccharides bearing an azido (N3) and
a N-Phth moieties as precursors of the free and N-acetylated
amino group, respectively [256]. The stereoselectivity of the
glycosylation reaction between the C-2 azido donor 71 and
N-Phth 72 acceptor met with little success, lowering the yield of
the desired anomer significantly. The obtained disaccharide was
converted to the trichloroacetimidate donor and used in a
[2 + 2] glycosylation, affording the tetramer 74 with an alter
nated N-acetyl pattern (Scheme 11A) [257]. Partially N-acety
lated COS dimer and tetramer were obtained exploiting the
orthogonality of the azide and N-Troc groups [258]. β-Selec
tivity during the glycosylation with the C-2 azido trichloroacet
imidate donor 75 was controlled by SN2 displacement of the
α-trichloroacetimidate LG upon activation with BF3·OEt2 in
CH2Cl2/n-hexane (3:2) (Scheme 11B). The orthogonal
N-trichloroacetyl (N-TCA) and N-benzyloxycarbonyl (N-Cbz)
PGs permitted the synthesis of chitobioses with different PA.


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1995
Scheme 12: AGA of well-defined COS with different PA using two orthogonally protected BBs. The AGA cycle includes coupling (TMSOTf), capping (Ac2O), and Fmoc deprotection (piperidine).
Scheme 10: Synthesis of COS using an orthogonal glycosylation strategy based on the use of two different LGs.
N-TCA groups could be converted into N-acetates upon reduc
tion with tributyltin hydride and azobisisobutyronitrile (AIBN),
and the N-Cbz groups were removed to liberate the free amino
groups during hydrogenolysis over Pd/C [259].
A collection of well-defined COS with defined DP and PA was
prepared by AGA [93,157,260]. The automated solid-phase ap
Scheme 11: Orthogonal N-PGs permitted the synthesis of COS with different PA.
proach required only two BBs with the amino group protected
either with the N-TCA 79 or with the N-Cbz group 80
(Scheme 12). Compounds 81–85 served as standards to explore
the conformational space of COS with different PA. NMR anal
ysis and MD simulations revealed the importance of the
deacetylated residues, with the free amino group able to stabi
lize new geometries.
Many more N-protecting groups [217,261] are available and
could generate COS with defined PA, however, to date most of


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1996
Scheme 13: A) AGA of β(1–6)-N-acetylglucosamine hexasaccharide and dodecasaccharide. AGA includes cycles of coupling (NIS/TfOH) and Fmoc deprotection (piperidine). B) Convergent synthesis of a β(1–3)-glucosamine pentasaccharide.
them have shown significant drawbacks, decreasing the reactiv
ity of the BB during glycosylation or complicating the deprotec
tion steps. Orthogonality and stability become particularly
crucial when the goal is the multistep synthesis of long COS.
Other glucosamine-based polysaccharides
Other polymers of glucosamine based on the β(1–3) or β(1–6)
linkages exist, but have gained less synthetic attention. Never
theless, β(1–6)-linked GlcN oligosaccharides may act as poten
tial antitumor and immunostimulating agents [262] and could
become important synthetic targets. The synthesis of a β(1–6)
linked 9mer was demonstrated, using an isopropyl thioglyco
side donor [262]. Convergent [262] as well as linear iterative
[263] approaches were reported. A block coupling approach
enabled access to a collection of free amino or N-acetylated
structures up to 11mer [264]. Intramolecular glycosylation be
tween a thioglycoside and a free C-6 hydroxy group at the non
reducing end enabled the synthesis of β(1–6)-glucosamine
macrocyclic compounds [265]. The iterative glycosylation of
N-Phth protected 2-deoxy-2-aminothioglycosides allowed for
the combinatorial synthesis of short oligoglucosamines having
β(1–6) and/or β(1–4)-linkages [263]. Automated solution-phase
synthesis of β(1–6)-glucosamine oligosaccharides, ranging from
tri- to hexasaccharide, was obtained via iterative electrochemi
cal assembly [266]. A solid-phase automated approach deliv
ered β(1–6)-glucosamine hexasaccharide 87a and dodecasac
charide 87b (Scheme 13A) [267]. β(1–3)-Oligomer 90 was pre
pared as chitin mimetics (Scheme 13B). Despite the subtle
differences in the conformational behavior of the two ana
logues (β(1–3) vs β(1–4) oligomers), it was observed that the
β(1–3)-mimetic was still recognized by wheat germ agglutinin
and a chitinase enzyme, and could act as a moderate inhibitor of
chitin hydrolysis [268].
Mannose- and rhamnose-based polysaccharides
Due to the structural analogies between Rha (both ᴅ and ʟ) and
Man, we describe the polysaccharides based on these two units
in the same section. From a chemical point of view mannose
and rhamnose are ‘double-faced’ monosaccharides, as chemi
cally constructing α-linkage is relatively easy, whereas β-link
ages are still considered a major challenge in carbohydrate
chemistry (Figure 5). While long α-mannosides could be
accessed either by chemical synthesis or by polymerization
approaches, only relatively short β-mannan analogues could
be synthesized to date. In addition, limited enzymatic ap
proaches exist to assist with the synthesis of mannans and rham
nans.
α-Mannans
Mannans are widespread in nature, as constituents of the plant
cell-wall (β-mannans, based on the β(1–4)-Man linkage), or on
the surface of yeast and pathogens (α-mannans, where α(1–2),
α(1–3), and α(1–6) linkages can be found). No enzyme has been
reported for the synthesis of α-mannosides. Similarly, polymeri
zation approaches remain to date underrepresented.


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1997
Figure 6: Implementation of a capping step after each glycosylation cycle for the AGA of a 50mer oligomannoside 91. Uncapped 50mer and 49mer deletion sequence are eluted with virtually the same retention time. The capped 49mer (i.e., C-6 O-acetylated) is instead readily separated from the desired 50mer.
Figure 5: ‘Double-faced’ chemistry exemplified for ᴅ-Man and ʟ-Rha. Constructing β-Man linkages is considerably more challenging than constructing α-Man. β-Rha linkages present an additional challenge as PG-directed 1,2-cis glycosylations are not viable.
α-Mannosides can be reliably prepared through chemical glyco
sylation, which is in general highly α-stereoselective. Construc
tion of the 1,2-trans linkage of α-mannosides is conventionally
achieved with [142,157,269], or even without [270], neigh
boring group participation (e.g., Ac, Bz). The favorable
anomeric effect ensures efficient glycosylation reactions. The
synthesis of α-mannosides is widely established, allowing the
chemical synthesis of the longest polysaccharide to date (i.e.,
151mer). To speed up and simplify the solution phase synthesis
of long and well-defined polymannosides, iterative coupling
strategies are generally adopted [271,272]. Two monosaccha
rides are coupled yielding a disaccharide, which is parted and
converted to the new donor and acceptor. This process is
repeated iteratively allowing for an exponential length growth,
while maintaining control over the elongation. Beside more
common LGs such as phosphates, thioethers, and imidates,
ynenoate donors activated using Au(I) catalysis were success
fully employed in an iterative strategy, enabling the synthesis of
a 32mer [272]. The construction of α(1–6)-mannans (up to
10mer) bearing α(1–2)-Man branches was also accomplished
using phosphate, N-phenyltrifluoroacetimidate or n-pentenyl
orthoester donors [273,274].
An approach using a (cationic) ROP method using tricyclic
orthoester Man BBs considerably reduced the time needed for
the stereoselective synthesis of linear α(1–6)-mannans (ranging
from 5mer to 20mer) [275]. The biggest advantage of this ap
proach is the easy scalability, up to a gram scale. However, this
strategy is limited to one type of linkage (i.e., only α(1–6) link
ages) and does not allow for access to mannans with defined
length.
Total syntheses of mannose polysaccharides including a 30mer
[276], 50mer [277] and 100mer [278] were achieved by AGA.
Key optimizations including tuning of the PGs [277], adjust
ment of coupling time and temperature [278], and introduction
of a capping step [279] permitted to drastically improve overall
yields and to simplify the purification (Figure 6). The 100mer
93 was obtained with a calculated average stepwise yield of
98.75% (Scheme 14). Long α-mannosides have the advanta
geous feature of being highly soluble due to the high flexibility
of α(1–6)-Man backbone, facilitating the deprotection and
purification steps [157].


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1998
Scheme 14: AGA enabled the synthesis of a linear α(1–6)-mannoside 100mer 93 within 188 h and with an average stepwise yield of 98.75%. The AGA cycle includes glycosylation (NIS, TfOH), capping (Ac2O), and Fmoc deprotection (piperidine).
Scheme 15: The 151mer branched polymannoside was synthesized by a [30 + 30 + 30 + 30 + 31] fragment coupling. AGA enabled the synthesis of the α-mannoside 30mer donor fragment 96 and the branched 31mer acceptor fragment 95.
Naturally occurring mannosides, such as lipomannans found on
the cell surface of mycobacteria, normally consist of a α(1–6)
mannan core substituted with α(1–2) branches, commonly intro
duced exploiting orthogonal PGs (e.g., Fmoc and Lev)
[269,280,281]. These compounds could be prepared entirely on
a solid support, or following a solution-phase fragment (or
block) coupling. In this case, the branch produced by AGA, em
ploying a traceless linker [118], was converted into a glycosyl
donor and coupled to the mannan acceptor to create a dendron
like structure. To overcome the high steric hindrance of both
coupling partners, careful optimization of the LG and the reac
tion temperature was imperative [118,278,280,282]. A
[31 + 30 + 30 + 30 + 30] fragment coupling allowed assem
bling a 151mer polymannoside 97, the biggest synthetic poly
saccharide obtained to date (Scheme 15). Switching from a
N-trichloroacetimidate to a less reactive fluoride donor and
screening of the suitable activator was key to the success of the
coupling. As synthetic polymannosides have now reached the
size of macromolecules, new challenges are arising in terms of
purification and characterization. Gel permeation chromatogra
phy (GPC) and advanced high-resolution MS analysis are being
developed to address the need of these new available com
pounds [278,283].
β-Mannans and β-mannuronans
In contrast to α-Man linkages, the construction of β-Man glyco
sidic linkages is a major challenge (Figure 5). Absence of the
anomeric effect in the β-product and steric repulsion of the C-2
axial substituent make β-selectivity hard to achieve. Even
though, several methods have been developed to construct


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
1999
Figure 7: PG stereocontrol strategy to obtain β-mannosides. A) The mechanism of the β-mannosylation reaction is thought to proceed through a contact ion pair (CIP) in which the triflate anion shields the α-face favoring the nucleophile attack from the β-face. The solvent separated ion pair (SSIP) scenario is disfavored due to the benzylidene group locking the C5–C6 bond in the tg conformation which destabilizes the oxocarbenium ion. For a thorough explanation of the mechanism we refer to the original publication [289]. B) Examples of β-mannosides synthesized using the 4,6-O-benzylidene directed β-mannosylation strategy. C) Chain elongation beyond the trisaccharide level for β(1–2)-analogues presented a significant drop in yield and β-stereoselectivity due to the conformation of acceptor 103.
β-Man glycosidic linkages, the majority of them focused on the
construction of a single β-Man linkage [284,285]. Hydrogen
bond-mediated aglycone delivery (HAD) was recently em
ployed to construct a β(1–3) 2-O-acetyl-6-deoxy-mannohep
topyranose 4mer with excellent β-selectivity [286]. PG stereo
control by means of 4,6-O-benzylidene is to date the most
applied chemical strategy to construct β-mannosides [270]. In a
first stage, the donor (either a sulfoxide or a thioglycoside) is
pre-activated at low temperature with triflate-based activators.
After this step, the acceptor is added, leading to preferential for
mation of the β-mannoside [287]. The high stereoselectivity is
thought to derive from the high stability of the α-triflate inter
mediate, which dissociates generating a contact ion pair (CIP).
In the CIP, the triflate anion shields the α-face, allowing for the
preferential attack of the nucleophile from the β-face
(Figure 7A). The 4,6-O-benzylidene group disfavors the com
plete dissociation of the α-triflate to the corresponding solvent
separated ion pair (SSIP), preventing the formation of the
α-Man product [288,289].
Various β-mannosides (up to 8mer) with β(1–2), β(1–4) [290]
as well as mixed linkages β(1–3)/β(1–4) [291] were prepared
with high stereoselectivity (α:β ratio ca. 1:9) using PG stereo
control (Figure 7B, 99–101). Interestingly, the synthesis of
β(1–2) analogues suffered from a drastic decrease in stereose
lectivity (α:β ratio drop to ca. 1:4) and yield as the chain was
elongated beyond the 3mer stage (Figure 7C). This observation
was ascribed to the characteristic conformation of the protected
β(1–2)-trisaccharide acceptor 103, in which a compact helical
structure caused severe hindrance impacting the reactivity and
stereoselectivity [290,292]. This issue was not observed with
the β(1–4)-mannosides due to their more linear rod-like shape.
Overall, the wide variety of β-mannosides prepared under
scored the versatility of the 4,6-O-benzylidene directed
β-mannosylation to construct the challenging β-Man linkage.
Some limitations of the method occur when large Man donors
are used, especially when bulky substituents are present at C-3
position (α:β ratio can drop to 1.5:1) [291]. To date, the sulf


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2000
Scheme 16: A) Mechanism of 1,2-cis stereoselective glycosylation using ManA donors. Once the ManA donor is activated, the C-5 carboxylate stabilizes the oxocarbenium ion in a 3H4 conformation which favors formation of β-ManA linkages. B) Series of β(1–4)-oligomannuronates synthesized using AGA and ManA donors. The AGA cycle includes coupling (TfOH) and Lev deprotection (hydrazine). C) β(1–4)-Man and β(1–4)-ManA oligosaccharides prepared using fluorous-tag (FTag) assisted automated synthesis.
oxide donor pre-activation protocol and the low temperatures
needed (−78 to −60 °C) posed technical challenges to the imple
mentation of this method in AGA. Thus, carboxybenzyl donors
bearing a minimally intrusive PG at C-3 were employed in a
protocol that does not require pre-activation [293]. However,
only trisaccharides with β(1–4)/β(1–3) mixed linkage could be
isolated after challenging purification steps, indicating that
major limitations still exist for the AGA of β-mannosides.
Since stereoselectivity and yield are sensitive to the acceptor
conformation and nucleophilicity, the synthesis of some classes
of compounds remain hindered. To circumvent the challenge of
β-mannosylation using large donors, an indirect approach was
followed to construct β(1–4)-mannosides up to 8mer. The high
β-stereoselectivity of β-glucosylation was exploited in a [4 + 4]
fragment coupling. The subsequent C-2 epimerization, via an
oxidation–reduction step, converted the β-Glc into a β-Man
[294]. Similarly, an indirect approach using Glc orthoester
donors was applied for the synthesis of a 8mer based on β(1–2)
Man linkages. The newly formed β-Glc was converted to
β-Man by Swern oxidation of the hydroxy group at C-2, fol
lowed by reduction of the carbonyl group [295]. Other indirect
methods to synthesize β(1–2)-mannosides were also reported
using donors bearing a ketone functionality at C-2 (ulosyl
donors) which require a reduction step to obtain Man [296,297].
High β-selectivities were observed for mannuronic acid (ManA)
donors [298-301]. This result is thought to derive from
the unusual 3H4 conformation of the oxocarbenium ion interme
diate, stabilized by the pseudo-axial C-5 carboxylate
(Scheme 16A) [299,301]. The ManA donor enabled the conver
gent assembly of β(1–4)-ManA oligosaccharides up to 5mer,


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2001
with a α:β ratio of about 1:10 (in 50–70% yields) [299]. Impor
tantly, yield and β-stereoselectivity were not affected by the size
of the coupling partners, a key feature that makes this method
ology attractive to access long polysaccharides. This approach
was implemented in AGA to generate a collection of
mannuronic acid oligomers, ranging from 4mer to 12mer
(Scheme 16B, 106a–c) [302]. Key steps were the choice of the
temporary PGs (i.e., Lev), the LG (N-phenyltrifluoroacetimi
date), activation system (TfOH), and the coupling temperatures
(−40 °C) used for BB 105. An average 90% yield per step with
excellent β-stereoselectivity was observed. A solution-phase ap
proach allowed to reduce the amount of required donor
(1–2 equiv compared to 9 equiv) and to couple big fragments
(i.e., [4 + 4] and [8 + 8] glycosylations) without a significant
loss in β-stereoselectivity. A β(1–4)-ManA 16mer was pre
pared using this highly convergent and iterative approach [303].
The high β-stereoselectivity of ManA donors was capitalized to
access β(1–4)-Man 6mer 110, after reduction of carboxylate
moieties of β(1–4)-ManA 6mer 107 (Scheme 16C) [304]. The
fast assembly of a β(1–4)-ManA 6mer 107 (75% average yield
per step) was achieved by automated solution-phase synthesis
with the help of fluorous solid phase extraction (FSPE). Reduc
tion of the carboxylic acid moieties was achieved by diisobutyl
aluminium hydride (DIBAL-H) treatment.
Enzymatic approaches to access β-mannans are scarce in the lit
erature. The enzymatic synthesis of β(1–4)-mannans (up to DP
7) was reported using glycosynthase mutants of the
β-mannanase from Cellvibrio japonicas. α-Mannobiosyl fluo
ride donors were coupled to a Glc acceptor, to obtain the
desired product, albeit in a relatively low yield (5% for the
7mer) [305]. Recently, β(1–4)-mannans were synthesized using
a thermoactive glycoside phosphorylase from Thermotoga
maritima that catalyzed the reversible degradation of manno
sides by phosphorolysis. An initial screening of temperature and
pH, using the α-ᴅ-mannose 1-phosphate donor (αMan1P) and
ᴅ-mannose as the acceptor, identified optimal conditions (pH
6.0 and 60 °C), yielding mixtures of oligomers with a DP of 2
to 6. When a β(1–4)-mannoside 6mer was employed as
acceptor, higher DP could be reached. The longest oligomers
(DP between 7 and 16) precipitated into lamellar crystals with a
diffraction pattern typical of mannan I [306].
ManA-based polysaccharides are abundant component of algi
nates, often found as mixed polymers with α(1–4)-ʟ-GulA (i.e.,
guluronic acid). These naturally occurring anionic polysaccha
rides are found in algae and some bacteria [307]. The two
monosaccharides can be arranged in the polymer in different
patterns (i.e., MM, GG, or MG domains where M stands for
ManA and G for GulA). To date chemical synthesis is the only
Figure 8: A) The preferred 4H3 conformation of the gulosyl oxocarbenium ion favors the attack of the alcohol from the α-face. B) Key disaccharide BB 111 used for the solution phase synthesis of alginate oligosaccharides and representative structures obtained.
way to access well-defined alginate oligosaccharides as enzy
matic synthesis has suffered from the complexity of the en
zymes involved [308]. The chemical construction of α(1–4)-ʟ
Gul linkages is facilitated by the intrinsic tendency of Gul
donors to form 1,2-cis glycosidic linkages (α:β ratios >10:1).
The 4H3 conformation adopted preferentially by the Gul
oxocarbenium intermediate favors the attack of the nucleophile
from the α-face, leading to a 1,2-cis glycosylation (Figure 8A).
In contrast, GulA donors were found to be less α-stereoselec
tive [301,309,310]. Therefore, the most frequently adopted
strategies involve highly α-stereoselective glycosylations using
Gul donors and subsequent oxidation to obtain GulA [310].
With this strategy, alginate oligomers (i.e., 7mer) with mixed
sequence were prepared. The solution phase synthesis was per
formed by sequential addition of a disaccharide BB 111 with
the α(1–4) GulA glycosidic linkage pre-installed (α(1–4) gulo
sylation followed by C-6 oxidation). The ManA unit provided
high β-stereoselectivity (α:β >1:20) (Figure 8B). This strategy,
while avoiding late-stage oxidations, suffered from the poor re


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2002
Scheme 17: AGA of type I rhamnans up to 16mer using disaccharide BB 115 and CNPiv PG. The AGA cycle includes coupling (TfOH) and Lev deprotection (hydrazine).
activity of the axial OH-4 of GulA resulting in low glycosyla
tion yields for longer analogues (i.e., 30–42%). In addition, the
acceptor reactivity was found to be highly sensitive to subtle
modifications in remote positions of the acceptor [309,311],
highlighting the importance of the – often overlooked 
acceptor three-dimensional structure.
Rhamnans
Long repetitive polysaccharides constituted of ʟ-Rha (i.e.,
rhamnans) are found in bacteria, plants, and algae but are absent
in animals [312]. The enantiomer ᴅ-Rha is less common, only
found in the capsule of some bacterial species. Linear repetitive
rhamnans can be classified in type I (alternated α(1–3)/α(1–2)
ʟ-Rha residues) or type II (linear α(1–3)-ʟ-Rha residues) and
can be variously sulfated.
Very few examples of enzymatic or polymerization methods
have been reported to prepare this class of compounds. In
contrast, from a chemical standpoint constructing α-rhamnans
does not present significant challenges. Similar to Man, Rha
donors benefit from the favorable anomeric effect and neigh
boring group participation, generally achieved with C-2 O-acyl
groups (e.g., Ac, Bz, Piv), which secures highly stereoselective
1,2-trans glycosylations (Figure 5) [270,313-318]. Even in
absence of neighboring group participation α-stereoselectivity is
achieved [319,320].
α-Rhamnans chemical synthesis suffers from PG migration.
This issue has been observed when constructing α(1–3) link
ages, since C-2 O-Ac groups are prone to migrate from the axial
O-2 to the equatorial O-3 of ʟ-Rha [313,314,321,322].
Replacing the Ac group with benzoyl (Bz) [315], pivaloyl (Piv),
or cyano-pivaloyl (CNPiv) [313,314] groups prevented acyl
migration. In particular, CNPiv was developed to avoid the
harsh conditions generally required for Piv removal and could
be easily cleaved either by hydrogenolysis [313] or methanoly
sis [314]. Type I rhamnans up to 16mer (116a–e) were pre
pared by AGA using disaccharide BB 115 (Scheme 17) [314].
Type I and II α-rhamnans were also successfully assembled
following solution-phase approaches by stepwise elongation of
the rhamnan chain using orthogonally protected disaccharide
BBs. The range of orthogonal PGs used (i.e., PMB, Bz, Nap,
Bn) suggested the possibility to generate rhamnan structures
with different sulfation patterns [315,316]. Orthogonality of
PGs was also exploited to introduce β(1–3)-GlcNAc branches
on a type I rhamnan 8mer backbone, common in bacterial
α-rhamnans [317].
In analogy to mannose, β-rhamnosylation is a highly chal
lenging reaction. However, while the β-mannosylation reaction
can benefit from 4,6-O-benzylidene PG stereocontrol, β-rham
nosylation cannot [323]. To date, only few reports of successful
β-rhamnans synthesis are available, mostly limited to short
oligosaccharides [324].
Polysaccharides based on a mixed mannose–rhamnose backbone
The lack of enzymatic approaches to construct the often unique
linkages found in bacterial polysaccharides makes chemical
synthesis the only amenable way to access these molecules.
Generally, the repeating unit containing the challenging linkage
is prepared and used in iterative glycosylation approaches
enabling exponential growth, while maintaining control over the
polysaccharide length.
Recently, the synthesis of large bacterial polysaccharides con
taining ᴅ-Man, and ᴅ/ʟ-Rha mixed structures was reported
[325,326]. The O-antigen of Bacteroides vulgatus consisted of
alternating α(1–3)-ʟ-Rha and β(1–4)-ᴅ-Man linkages. The effi
cient α-rhamnosylation reaction was exploited to elongate the
chain by iterative glycosylations, while the challenging β(1–4)
Man was installed at the disaccharide level (117) using the 4,6
O-benzylidene directed β-mannosylation (Figure 9A). The
exponential growth, up to the 128mer (118a–h), was enabled by


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2003
Figure 9: Key BBs for the synthesis of the O-antigen of Bacteroides vulgatus up to a 128mer (A) and the CPS of Clostridium bolteae up to 18mer (B). The most challenging 1,2-cis glycosidic linkage is installed in the key BBs and highly stereoselective 1,2-trans α-rhamnosylation or α-mannosylation were exploited for elongation.
o-alkynylbenzoate donors [327] and the use of two orthogonal
PG at the reducing and non-reducing end (i.e., p-methoxy
phenyl (PMP) and tert-butyldimethylsilyl (TBS) groups, respec
tively). The glycosylation reactions proved robust, with only a
slight drop in yield (i.e., 74% compared to ca. 90%) for the
[64 + 64] glycosylation. Issues during the final deprotection
steps, due to poor solubility and reducing end degradation
[294], lowered the isolated yield to 15% for the longest ana
logues [325].
The capsular polysaccharide (CPS) of Clostridium bolteae,
consisting of alternating α(1–4)-ᴅ-Man and β(1–3)-ᴅ-Rha, was
targeted to showcase a methodology to construct β-ᴅ-Rha link
ages. Similar to the above approach, the disaccharide BB 119
including the challenging β(1–3)-ᴅ-Rha glycosidic linkage was
initially prepared (Figure 9B). The efficient α-mannosylation
reaction was exploited to further elongate the chain in a sequen
tial manner. Three different strategies were screened for the
construction of the dimer: i) β-rhamnosylation through a pre-ac
tivation strategy, ii) 4,6-O-benzylidene directed β-mannosyl
ation and subsequent C-6 deoxygenation to provide ᴅ-Rha,
iii) indirect approach using 6-deoxy-ᴅ-Glc in a 1,2-trans glyco
sylation and subsequent C-2 epimerization to give ᴅ-Rha.
Strategies ii) and iii) successfully formed the β(1–3)-ᴅ-Rha
linkage of the disaccharide BB. A series of sequential glycosyl
ations enabled the solution-phase assembly of oligosaccharides
up to 18mer (120a–i) in excellent yields (80–90% per
coupling). The deprotection (i.e., methanolysis and hydro
genolysis) proved to be challenging for longer analogues due to
the degradation of the oligosaccharides in the acidic solvent
chosen for hydrogenolysis. A neutral solvent mixture permitted
to obtain the compounds, even though in low yield compared to
shorter analogues [326].
Galactose-based polysaccharides
Enzymatic and polymerization approaches are not so common
for galactopyranose-based polysaccharides and are limited to
the construction of single glycosidic linkages [328]. In contrast,
bacterial enzymes capable of constructing galactofuranose
based polysaccharides have been widely studied and offer the
unique possibility to tune the chain length. Additionally, chemi
cal synthesis can reliably afford both α-Gal and β-Gal polysac
charides.
β-Galactans
Galactans and arabinogalactans, together with arabinans, are the
three types of side chains in the pectin RG-I domain
[99,329,330]. The backbone of type I galactans is made of
β(1–4)-linked Gal residues, while type II galactans are highly
branched polysaccharides composed of β(1–3)- or β(1–6)
linked Gal residues [99].
β-Galactosylation is easily achieved by neighboring group par
ticipation. The main challenge of type I galactans is the low re
activity of the axial hydroxy group at C-4 of the Gal residues.
Type I galactans up to 7mer (121a–c) have been prepared em
ploying C-2 O-Piv or O-Ac PG and either n-pentenyl or thiogly
coside LG (Figure 10) [331-333]. Steric bulk around the unreac
tive C-4 OH was minimized by using Bn or allyl (All) ethers at
C-3 and C-6 positions [331]. Removal of Piv, despite requiring
harsh conditions (LiOH in MeOH under reflux or Et4NOH in
THF under reflux), yielded the desired product in good yield
(70–90%). In contrast, removal of allyl (All) PG was more chal
lenging, requiring extensive optimization [331]. The use of Nap
to mask the hydroxy groups at C-4 or C-6 allowed for the late
stage installation of arabinan side chains [332]. AGA was em
ployed to assemble a collection of type I galactans using three


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2004
Figure 11: A) The DTBS PG stabilizes the 3H4 conformation of the Gal oxocarbenium ion favoring the attack of the alcohol from the α-face in a SN1 manner. B) Key BBs used in the synthesis of galactosaminogalactans bearing the α-directing DTBS PG.
different Gal BBs equipped with Fmoc as a temporary PG to
allow for chain elongation. Lev could be selectively removed to
install ʟ-arabinose branches at the C-3. The low reactivity of the
hydroxy group at C-4 required a double cycle of glycosylation
and negatively impacted the final yields [334].
Figure 10: Examples of type I and type II galactans synthesized to date.
The easy formation of β-Gal linkages and the excellent reactivi
ty of the primary hydroxy group at C-6 considerably simplified
the synthesis of type II galactans. Solution-phase synthesis pro
vided long β(1–6)-galactans, bearing α(1–2)- or α(1–3)-linked
ʟ-arabinofuranose side-chains [335-338]. A stepwise elonga
tion (i.e., [4 + 12] then [4 + 16]) proved successful to construct
a 20mer β(1–6)-galactan, bearing arabinose side chains [338]
(123, Figure 10).
Only shorter synthetic oligomers based on a β(1–3)-Gal back
bone could be obtained (122a,b). A collection of linear and
branched type II galactans was synthesized by solution-phase
methods. To minimize PG migration, the use of thioglycoside
disaccharide donors bearing a participating Piv ester at C-2
position was the key [339]. Similar structures were obtained by
AGA [340]. In both cases, orthogonal PG were necessary
for the installation of either β(1–6)-Gal or α(1–3)-Araf
branches.
α-Galactans and α-galactosaminogalactans
In contrast to the challenging formation of other 1,2-cis link
ages, α-galactosylation can be reliably obtained using Kiso’s
di-tert-butylsilylene (DTBS)-directed α-stereoselective method
ology (Figure 11A). Upon activation, the galacto-type oxocar
benium adopts a 4H3 conformation, preferentially attacked from
the α-face in a SN1 mechanism due to the steric bulk of the
DTBS group. The 4H3 conformation is stabilized by through
space electron donation from the DTBS group. Complete
α-stereoselectivity is often preserved, even in presence of C-2
participating PGs [341,342].
This methodology was elegantly implemented for the synthesis
of galactosaminogalactans, linear heteropolysaccharide found in
the cell-wall of the fungus Aspergillus fumigatus (Figure 11B)
[343,344]. Natural galactosaminogalactans are composed of
Gal, GalN, and GalNAc arranged in a random pattern impeding
their isolation from natural sources. A sequential strategy using
BBs 124, 125, and 126 afforded a collection of α(1–4)-Gal,
α(1–4)-GalN, α(1–4)-GalNAc, including mixed structures. The


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2005
Figure 12: Homogalacturonan oligosaccharides synthesized to date. Access to different patterns of methyl-esterification could be controlled using BBs 133a and 133b bearing different C-6 PGs (i.e., Ac or PMP).
use of the highly reactive N-phenyltrifluoroacetimidate glycosyl
donors 126 proved to be crucial to generate long oligosaccha
rides. Chain elongation was achieved by DTBS removal and
selective benzoylation of the OH at C-6, yielding the free C-4
hydroxy group to be used as acceptor in the next glycosylation.
Good yields (80–90%) and excellent α-stereoselectivities were
obtained for the construction of oligomers up to 12mer (127,
128, 129a–d, 130a–d, 131a–d). The deprotection of α(1–4)-Gal
8mer and 9mer suffered from low yields (20–30%), due to low
solubility in water. Higher yields were obtained for more
soluble analogues [343,344].
The pectin domain homogalacturonan (HG) consists of a linear
backbone of α(1–4)-GalA residues in which the C-6 carboxyl
ate moiety can exist as methyl ester, generating different
patterns [99,329,330]. While the stereoselective construction of
the α(1–4) linkages did not pose a significant challenge, the
poor acceptor reactivity due to the presence of the carboxylate
moiety often translated into low yield [99]. HG analogues (up to
a 12mer, 132a,b) were successfully synthesized by solution
phase synthesis (Figure 12). Solvent participation with Gal fluo
ride donors (activated with SnCl2, AgClO4) ensured high
α-stereoselectivities. The Gal residues were converted to GalA
by selective hydrolysis of the Ac ester at C-6 and a two-step ox
idation (i.e., Swern oxidation followed by treatment with
NaClO2 in aqueous acidic conditions) [345,346]. An alternative
oxidation protocol (Dess–Martin periodinane/NaClO2) was
applied to synthesize HG fragments with different methylation
patterns (134a–d). Two orthogonal PGs (Ac and PMP) were
installed at C-6 of the α(1–4)-Gal fragments, allowing for selec
tive oxidation (Figure 12). Methylation (with TMSCHN2) or
benzylation (with PhCHN2) of the carboxylic acid allowed to
differentiate between the carboxylic acids and obtain the methyl
ester or the carboxylic acid, respectively [347,348]. Overall,
while requiring more PG manipulations, the post-glycosylation
oxidation strategy proved to be higher yielding compared to a
procedure using GalA donors [349].
Galactofuranose-based polysaccharides
The cell wall of mycobacteria contains galactofuranose (Galf)
based polysaccharides that play various functional roles based
on their length [350]. These polymers are biosynthesized in a
length-controlled manner by complex enzymatic machineries.
However, to date, the molecular mechanism for chain length
control remains poorly understood [351].
The galactan found in Mycobacterium tuberculosis is composed
of 20–40 Galf residues connected via alternated β(1–5)- and
β(1–6)-linkages. The in vitro enzymatic synthesis of these
galactans has been reported using galatofuranosyltransferase
(GlfT2) from Mycobacterium tuberculosis, UPD-Galf donor,
and acceptor 135c (Figure 13). The resulting polysaccharide
showed a product distribution unbalanced towards larger poly
mers (up to 27mer), with a narrow distribution centered on the
21mer. The nature and length of the lipidic part was a key pa
rameter to control the in vitro polymerization. While 135a and
135b did not function as efficient acceptors, longer galactans
with distribution centered on the 41mer could be obtained
tuning the lipid length (acceptor 135d) [352]. The mechanism
of galactan length control may differ consistently between the
in vitro and in vivo setting as the interplay between the GlfT2
enzyme, the plasma membrane and other proteins involved in
transport across the membrane play a crucial role in length
control [353,354]. Recently, it was reported that a mutation on
the GlfT2 enzyme enabled the regulation of the galactan chain
length (4mer or 11mer with a relatively narrow distribution)
[350]. These examples suggest a potential avenue to produce
length-controlled polysaccharides via glycoengineering
[351,354,355].
The main challenges associated to the chemical construction of
alternated β(1–5)- and β(1–6)-linked ᴅ-Galf residues are the
complexity of Galf BB synthesis. Especially for Galf, the lower
thermodynamic stability compared to its pyranosic counterpart,
makes BBs synthesis more complex [356-359]. Common ap


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2006
Figure 14: The poor reactivity of acceptor 137 hindered a stepwise synthesis of the linear galactan backbone at the 3mer stage. In contrast, acceptor 136 proved to be more reactive.
Scheme 18: AGA of a linear β(1–5) and β(1–6)-linked galactan 20mer. The AGA cycle includes coupling (NIS/TfOH), capping (Ac2O) and Fmoc deprotection (DBU).
Figure 13: GlfT2 from Mycobacterium tuberculosis catalyzes the sequential addition of UPD-Galf donor to a growing galactan chain composed of alternated β(1–5)- and β(1–6)-linked ᴅ-Galf.
proaches to access Gal in the furanose form involved dithio
acetal cyclization using iodine and an alcohol [358] or a
recently reported pyranoside-into-furanoside (PIF) rearrange
ment [360]. Frequent O-5→O-6 ester migration is observed in
basic media. The migration could be reduced by using morpho
line, instead of piperidine, during the Fmoc deprotection permit
ting the synthesis of a 7mer upon stepwise chain elongation
[358,359]. Other approaches employing Lev as a temporary PG
yielded a 14mer galactan [361]. Interestingly, while a good re
activity of acceptor 136 was observed, the poor reactivity of
acceptor 137 hindered the stepwise synthesis of the linear back
bone, already at the 3mer stage (Figure 14). This poor reactivi
ty was ascribed to the unfavorable conformation adopted by
137. This problem was solved by building the galactan back
bone from the non-reducing end to the reducing end [358].
Galactan fragments, up to 20mer, were prepared by AGA
(Scheme 18). When BBs 138a and 139a were used, several
problems were encountered such as poor solubility, aggrega
tion of the growing chain on the solid support and instability.
Switching to BBs 138b and 139b bearing disarming Bz groups
solved the issue and enabled the assembly of galactans up to
20mer 140 [362].


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2007
Fucose-based polysaccharides
Fucans are a class of ionic polysaccharides present on the cell
wall of marine brown algae, mainly constituted of repeating
ʟ-fucose units [363]. They are heavily sulfated and connected
through α(1–3) or α(1–4) linkages [364]. Several orthogonal
PGs are required to access different sulfation patterns present in
fucans. Long structures (up to 16mer) with α(1–3) connectivity
were obtained by iterative couplings of dimers and tetrasaccha
rides units [365]. Donors bearing 4-O-benzoyl, in combination
with the 3-O-Ac and 2-O-Bn groups, enhanced the α-selectivity
through remote participation. To date, only short tetramers con
taining both types of α-linkages have been reported [366].
Arabinose-based polysaccharides
Arabinans, repetitive polysaccharides containing arabinofura
nose (Araf), are major constituents of both plant cell-wall and of
mycobacterial cell-wall, with the important difference that
plants contain ʟ-Araf, while bacteria ᴅ-Araf [367]. Mycobacte
rial arabinans are composed of a linear backbone of α(1–5)-ᴅ
Araf with α(1–3) branches, which can be further elongated with
linear α(1–5)-ᴅ-Araf residues. Similarly, plant arabinans consist
of α(1–5)-ʟ-Araf bearing α(1–3) and/or α(1–2) branches.
A variety of strategies have been reported to synthesize these
compounds. Most of them show several common features. Bz
groups are the most commonly used neighboring participating
groups to ensure stereoselectivity, affording the linear α(1–5)-ᴅ
Araf backbone. Convergent strategies are commonly employed
[368]. As an alternative approach, cationic ROP using 1,2,5
orthobenzoate BBs and Lewis acid catalysis (i.e., SnCl4 or
TMSOTf) could generate mixtures of linear α(1–5)-arabinans
(up to 25mer) [369-371]. Using 1,2,5-orthopivaloate BBs, linear
α(1–5) arabinans with DP up to 91 could be prepared [372].
Tuning the polymerization conditions gave mono-, di-, and tri
saccharide thioglycoside Araf BBs, that were used to assemble
defined linear arabinans (up to 8mer) [373].
When constructing branched arabinans, convergent approaches
involving fragment coupling, rather than sequential elongation,
are preferred. Steric hindrance at the arabinan acceptor was
found to be the limiting factor during the installation of the
α(1–3)-arabinan branches. Small Araf donors enabled the instal
lation of C-3 branches in a 12mer [374,375]. Larger structures
(up to 22mer) were synthesized by convergent fragment cou
pling [376,377]. Key to the success of these syntheses was the
early stage installation of the α(1–3) branches and the single
β(1–2)-linked Araf at the non-reducing end. Trichloroacetimi
dates were chosen as reactive LGs for the most challenging
couplings (i.e., [12 + 3 + 3], and [12 + 5 + 5]). To avoid the
removal of a large number of Bn groups at the last stage of the
synthesis, Bz groups were chosen as the sole PGs for the frag
ments [376]. The reactivity of Araf permitted the implementa
tion of milder glycosylation conditions; 1,2-propargyl
orthoester donors and alkynyl carbonate donors, activated using
a Au(I) catalyst in presence of AgOTf, were employed in the
convergent synthesis of a 25mer. The glycosylation could be
carried out at room temperature [368,378-380]. Shorter
branched structures (up to 6mer) could be assembled by AGA
using thioglycoside donors [281,381].
Fewer examples exist for the chemical synthesis of ʟ-arabinans.
A convergent assembly of a α(1–5)-linked 8mer was
accomplished with ʟ-Araf N-trichloroacetimidate donors.
Regioselective glycosylation of the primary alcohol at C-5 on
partially protected acceptors was possible, simplifying BB prep
aration. However, this reaction was shown to be highly
acceptor-dependent and worked best only for Araf acceptors
[382,383].
Recently, the synthesis of the whole complex arabinogalactan
polysaccharide 92mer was reported. A linear 30mer backbone
of alternated β(1–5)- and β(1–6)-linked ᴅ-Galf residues bearing
two branched 31mer arabinan was assembled in a convergent
approach. Two equivalents of a branched arabinan donor (bear
ing α(1–5) and α(1–3) linkages) were coupled to a linear
galactofuranose (30mer) backbone acceptor in a [31 + 31 + 30]
glycosylation step (Figure 15).
The three fragments were assembled following one-pot proto
cols, in which the donor was pre-activated at low temperature
(stoichiometric pTsCl/AgOTf at −78 °C) and then the acceptor
was added [154]. Upon completion of the reaction, the newly
formed compound was subjected to the same pre-activation
protocol and employed in the following step without intermedi
ate purification. In this way, the alternated linear β(1–5)- and
β(1–6)-linked ᴅ-Galf 30mer fragment was quickly obtained via
a five-component one-pot glycosylation [6 + 6 + 6 + 6 + 6].
Each 6mer was itself generated via a six-component one-pot
protocol. Similarly, branched arabinofuranose fragment 145
was assembled following a six-component one-pot glycosyla
tion [7 x 2 + 5 + 6 + 6] (Scheme 19). To avoid late-stage
installation of challenging linkages, the β(1–2)-Araf terminal
residues were installed at an early stage using a 3,5-TIPDS
protected (3,5-O-tetraisopropyldisiloxanylidene) Araf donor
[384].
The three fragments were finally connected using the benzene
sulfinylmorpholine/triflic anhydride (BSM/Tf2O) activator
system. Despite the impressive size of the molecule, no issues
were encountered in the final deprotection steps (75% yield),
permitting to obtain 92mer arabinogalactan polysaccharide 140
[385].


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2008
Figure 15: The 92mer arabinogalactan was synthesized using a [31 + 31 + 30] fragment coupling between a 31mer arabinan donor (Araf31) and a 30mer galactan acceptor (Galf30).
Scheme 19: Synthesis of the branched arabinofuranose fragment using a six component one-pot synthesis. i) TTBP, 4 Å MS, DCM, pTolSCl, AgOTf then 143, −78 °C to room temperature. ii) pTolSCl, AgOTf then 144, −78 °C to room temperature. iii) pTolSCl, AgOTf then 144, −78 °C to room temperature.


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2009
Figure 16: A) Chemical structure and SNFG of the representative disaccharide units forming the GAG backbones, and B) representative examples of synthetic disaccharides used for the preparation of HS analogues.
Glycosaminoglycans (GAGs)
Ionic polysaccharides are ubiquitous in living organisms where
they regulate a multitude of cell functions. The ionic moieties
control the shape of such compounds by promoting repulsive
and attractive interactions [9]. Glycosaminoglycans (GAGs) are
the major structural components of the extracellular matrix
(ECM) in mammals. GAGs are linear, negatively charged poly
saccharides composed mainly of repeating disaccharide units
(Figure 16A) [386]. The anionic backbone, bearing sulfate
moieties (except for hyaluronans), is responsible for their inter
actions with a plethora of proteins and the regulation of a large
number of biological processes [387-389]. GAGs are water
retaining polysaccharides, thus modulating the hydration and
the water homeostasis in tissues [390].
GAGs can be obtained from animal sources (e.g., chondroitin
sulfate is extracted from shark cartilage), albeit in heterogen
eous mixtures that hampered quality control and reproducibility
[391]. The heterogeneous nature of these samples is particular
ly problematic because the spatial orientation of the sulfate
groups (sulfation code) [392,393] and the length of the polysac
charide chain affects the structural and biological features of
GAGs. This became obvious during the “heparin crisis” in
2008, when batches of heparin, contaminated with oversulfated
chondroitin sulfate, entered the marketplace causing the life of
hundreds of people [4]. This episode underscored the urgency to
develop reliable methods to access well-defined GAGs, with
full control over substitution pattern and chain length. Well
defined GAGs are also valuable standards to uncover the mech


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2010
Scheme 20: Degradation of natural heparin and heparosan generated valuable disaccharides 150 and 151 that can be further converted into four disaccharide BBs 152–155 to assemble well-defined structures.
anism of action of heparin-like drugs (e.g., fondaparinux)
[394,395].
Heparin and heparan sulfate
Among GAGs, heparin (H), heparan sulfate (HS), and heparin
like structures have been studied extensively due to their bio
logical relevance [389]. HS binds to over hundred proteins
depending on sulfation pattern and chain length. Generally, a
minimal length (in most cases an octasaccharide) is required to
trigger specific biological events, including interaction with
cytokines and chemokines growth factors [396].
Due to their structural complexity, the synthesis of H/HS poses
multiple challenges (Figure 17) [397]. The formation of the 1,2
cis linkage in the GlcN-GlcA repeating units cannot be directed
with neighboring group participation. A plethora of PGs has
been used to ensure or enhance α-stereoselectivity, through
remote participation and/or electronic effects. In addition, or
thogonal PGs should also be strategically placed to allow for the
subsequent regioselective sulfation. This requirement becomes
particularly challenging considering the multiple steps needed
to generate the rare ʟ-idose unit. Another bottleneck arises from
the lability of the sulfate groups in both acidic and basic condi
tions, limiting PG manipulations or functional group transfor
mations. Thus, the removal of the PG must be carefully planned
to avoid small pH fluctuations. Not last, purification
and detection of highly sulfated structures is troublesome
[398,399].
Figure 17: Synthetic challenges associated to the H/HS synthesis.
The significant efforts of the last 20 years resulted in synthetic
methods to access various BBs for the assembly of heparin and
heparan oligosaccharides. Considerable success has been ob
tained in making the core dimers IdoA-GlcN that can be further
assembled to give longer oligomers [400-404]. Still, most
methods suffered from lengthy and laborious processes (18–29
steps) and low yields that precluded scalability (Figure 16B).
Recently, a clever approach suggested the controlled hydrolysis
of commercially available heparin and heparosan polymers to
overcome the challenges associated with the chemical synthesis
of the disaccharide cores (Scheme 20) [405]. NMR spectrosco


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2011
Scheme 21: A) The one-step conversion of cyanohydrin 156 to ʟ-iduronamide 157 represent the key step for the synthesis of BB 158. B) Synthesis of long heparin-like structures using iterative coupling strategies.
py revealed that, after acid hydrolysis, both polymers produced
one type of dimer as the major product (e.g., A-B or B-A).
Epimerization strategies (i.e., GlcA→IdoA) granted access
to the other two dimers present in HS. The introduction of
orthogonal PGs and selective sulfation, provided a set of
disaccharides in high yields (9% overall) to be used in the syn
thesis of well-defined heparin-like structures. To date, this scal
able and efficient approach was applied to the synthesis of
tetramers.
Impressive results in terms of scalability were achieved starting
from the diastereomerically pure cyanohydrin 156 that was
quantitatively converted to ʟ-iduronamide 157 [406]. Upon suit
able PG manipulations, compound 157 was transformed into
acceptor 158 that enabled the formation of the challenging
α(1–4) glycosidic linkage with the 2-azidoglucoside donor
(Scheme 21). The synthesis of a 12mer was achieved using iter
ative couplings of compound 159. Cleavage of the ester PGs,
O-sulfonation, azide reduction and debenzylation, followed by
final N-sulfonation permitted the first gram-scale synthesis of a
heparin-related 12mer 161 [407].
A similar iterative strategy, using tetrasaccharide BB 162 [408],
led to the successful synthesis of a collection of protected HS
analogues, from 16mer to 40mer [409]. The use of tetrasaccha
ride 162 permitted to reduce the number of purification steps
after each iterative coupling and improve the overall yields.
From this collection, the 20mer was further transformed into
two homogeneous HS-like oligosaccharides 164 and 165 with
different sulfation patterns (Scheme 21B).


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2012
Despite these impressive results, chemical methods based on
repetitive coupling steps, deprotections, and purifications are
extremely labor demanding. Enzymatic synthesis offers an al
ternative approach to shorten these lengthy procedures. Never
theless, a purely enzymatic approach has been proven inade
quate for the synthesis of long GAGs, because it generates ill
defined mixtures of oligomers with different lengths [410]. A
chemoenzymatic approach could be the ideal solution to prepare
well-defined heparin structures [399]. Key to a successful
chemoenzymatic route is to design a sequence that resembles
the in vivo biosynthesis. Bacterial glycosyltransferases
(GTases) KfiA and PmHS2 are commonly used for the elonga
tion of a starting disaccharide using UDP-GlcNAc 169 and
UDP-GlcA 168 activated sugar donors [411]. N- and O-sulfo
transferases (STases) catalyze the regioselective insertion of the
sulfate moieties using 3’-phosphoadenosine 5’-phosphosulfates
(PAPS). To facilitate the detection and the purification steps,
the acceptor could be covalently attached to a UV detectable
chromophore, such as para-nitrophenol [412] (p-NP), or a fluo
rous tag [413]. Chemical modifications, tolerated by the en
zyme, were used to overcome particular bottlenecks of the
purely enzymatic approach. For example, while the natural sub
strate for KfiA (UDP-GlcNAc 168) proved very stable to N-de
acetylation, the unnatural donor [414,415] UDP-GlcNTFA 167
could be efficiently N-deacylated under mild basic conditions,
permitting subsequent regioselective N-sulfation. Variation on
the chemical backbone were catalyzed by C5-epimerase (C5
epi), able to convert GlcA into IdoA and vice versa [416].
Recent studies revealed that C5-epi recognizes specific binding
domains, promoting reversible or irreversible epimerization
[417]. Following these paths, low-molecular-weight heparins
(LMWH) were produced in a gram scale. Longer structures (up
to 21mer, 172a–d) were also accessible (Scheme 22A) [418].
Still, the preparation of structures containing a large number of
IdoA2S-GlcNS6S remains problematic. A random epimeriza
tion may happen in the presence of C5-epi, leading to ill
defined mixtures of GlcA and IdoA in the final product. A
pioneering strategy demonstrated that epimerization could be
successfully controlled with the selective introduction of a 6-O
methyl ether on a GlcN residue (Scheme 22B) [419]. Three
model hexasaccharides 173, 174, and 175 demonstrated how
single site substitutions can be key to direct enzymatic modifi
cations and generate knowledge on enzyme specificity.
Others GAGs
Chondroitin sulfate (CS) is comprised of β(1–4)-linked
N-acetyl-ᴅ-galactosamine (ᴅ-GalNAc) and β(1–3)-linked
ᴅ-glucuronic acid (ᴅ-GlcA) repeating units (Figure 16A).
Dermatan sulfate, also named chondroitin sulfate B, is an ana
logue of CS, having IdoA instead of the GlcA repeating unit. In
analogy to heparin and HS, the sulfation pattern dictates the
interaction with other biomolecules resulting in important bio
logical functions such as cell proliferation, tissue morphogen
esis, and wound repair [420].
To date, the longest CS chain chemically synthesized was a
24mer [421]. To ensure stereocontrol, the nitrogen on the GalN
unit was equipped with a participating PG, which can be after
wards easily removed to release the free amine. The screening
of different disaccharide donors revealed that the di-4,6-O-acet
ylated GalNTFA gave the desired β-selectivity. However, the
formation of a stable oxazoline side-product during the glyco
sylation of bigger and less reactive acceptors limited this ap
proach. Replacement of TFA with TCA and use of Bn groups
instead of the electron withdrawing esters limited the formation
of the oxazoline side-product. Iterative couplings of dimer 179
allowed for the synthesis of the protected 24mer (Scheme 23).
The cleavage of the Lev groups liberated the hydroxy groups
that were sulfated using SO3·NEt3. Different methods were
attempted for the removal of the TCA groups, which proved to
be very stable. Finally, a concentrated ammonia solution
permitted the cleavage of the twelve TCA moieties to give com
pound 181, after hydrogenolysis.
A total of 15 CS oligosaccharides with different sulfation
patterns, ranging from trisaccharides to nonasaccharides, were
enzymatically synthesized to investigate their biological func
tion [422]. The glycosyl transferase KfoC [423], extracted from
the E. coli K4 strain, permitted to transfer both UDP-GalNAc
and UDP-GlcA. The backbone could be prepared in a gram
scale, thanks to the UDP-sugars obtained from cheap starting
materials. This approach proved to be highly divergent, because
KfoC tolerated the unnatural substrate GalNTFA, which could
be chemically transformed to either an amine or an azide for
further functionalization. A collection of well-defined oligosac
charides with natural and unnatural sulfation patterns were pro
duced on multi-milligram scales.
Hyaluronic acid (HA) is the only non-sulfated GAG and is
composed of alternating GlcA and GlcNAc residues connected
through β(1–3) and β(1–4) glycosidic linkages, respectively
(Figure 16A). HA is a major component of the extracellular
matrix and is involved in many essential biological processes
[424] such as cell adhesion, cell migration, and wound healing.
Its mode of action is length-dependent; thus much effort has
been put to obtain defined hyaluronans of different lengths. The
low reactivity of the GlcA as glycosyl donor is the major syn
thetic challenge, generally overcome by the use of the more
reactive Glc donor followed by a post-glycosylation oxidation
to convert it to GlcA. Issues associated to GlcNAc concern the
protection of the amino group: TCA, commonly used to direct
the formation of the β-linkages through participation, often led


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2013
Scheme 22: A) Chemoenzymatic synthesis of heparin structures, using different types of UDP activated natural and unnatural monosaccharides. The steps follow the in vivo biosynthesis of such compounds. B) Selective epimerization of hexasaccharides 173, 174, and 175 revealed how single-site methylation can affect the function of C5-epi.
Scheme 23: Synthesis of the longest synthetic CS chain 181 (24mer) using donor 179 and acceptor 180 in an iterative approach.


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2014
Scheme 24: AGA of a collection of HA with different lengths. The AGA cycle includes coupling (TfOH) and Lev deprotection (hydrazine).
to the formation of less reactive oxazolines. The use of
TMSOTf suppressed the formation of this side product
and allowed for the synthesis of a 10mer in moderate yields
[425].
A collection of hyaluronans, ranging from trimers to 15mer, has
been synthesized in an automated fashion on a solid-support
[426]. Disaccharide 182 was prepared in a multigram scale from
compound 183. The C-4 and C-6 hydroxy groups of GlcNAc
were masked as silyl ethers, providing ketals with excellent
stability to acidic conditions. A first glycosylation with mono
mer 183 ensured high yield of the first coupling to the solid
support. Iterative couplings with dimer 182 gave the protected
hyaluronans with well-defined lengths that were liberated from
the solid support and subjected to global deprotection to give
184a–c (Scheme 24).
HA oligomers were prepared chemoenzymatically, using
PmHAS, a unique class of bacterial enzymes that catalyze the
addition of both UDP-GlcNAc and UDP-GlcA monosaccha
rides [427]. Short oligomers (2-4mers) were obtained after step
wise enzymatic couplings, controlling the acceptor/donor molar
ratio. These oligomers served as synthons for the one-pot poly
merization. HA polymers formed from short length acceptors
displayed a very narrow MW distribution, as confirmed by
multi-angle light scattering experiments. The same strategy was
applied for the synthesis of homogeneous chondroitin polymers
and other derivatives [428].
Keratan sulfate (KS) consists of a N-acetyllactosamine back
bone (Figure 16) [429]. Different types of KS are present in the
cornea, cartilage, and brain, named KS I, KS II and KS III, re
spectively [430]. Despite some encouraging results, the synthe
sis of long KS is, to date, not reported. A chemoenzymatic ap
proach allowed for the step-by-step elongations of the back
bone, but remained limited to tetrasaccharides [431]. Hexasac
charides with different sulfation pattern were obtained by AGA
[432]. The low reactivity of the donor and the acceptor as the
chain length increases has limited the formation of longer struc
tures.
Overall, GAGs with well-defined composition, patterns and
lengths are needed to unlock the “sulfation code” and establish
structure–function correlations. Recent advances in chemical
and chemoenzymatic synthesis permitted the preparation of
impressive targets. Still, most procedures are lengthy and low
yielding, suffering from low reactivity or poor selectivity as the
polysaccharide chain grows. New automated procedures as well
as highly selective enzymatic transformations should be imple
mented to provide valuable alternatives to naturally sourced
GAGs.
Conclusion
Exploitation of polysaccharides has always relied on mixtures
of compounds extracted from natural sources. Much effort has
been put to understand how sequence, length, and substitution
pattern affect polysaccharides’ biological and material proper
ties [93,221,350]. Therefore, well-defined polysaccharide sam
ples become essential probes to establish structure–property
correlations and for reproducible biological studies
[93,221,350]. Polysaccharides with well-defined chemical
structures can be prepared synthetically following three main
approaches: i) enzymatic methods, ii) polymerization, and
iii) chemical synthesis. These approaches are complementary to
each other, offering advantages and limitations. Thus, in most
cases, the choice of the more suitable methods depends on the
desired application.
Enzymatic and chemoenzymatic methods showed enormous
potential for the synthesis of some classes of polysaccharides
(i.e., GAGs). The main advantages are the simple synthetic
protocols (no PGs required) and the high regio- and stereoselec
tivity, typical of enzymes. In contrast, the high specificity of the
enzymes hampers the introduction of unnatural moieties and
limits the scope of these methods. To date, not all glycosidic
linkages are accessible and repetitive polymers are often ob


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2015
tained as mixtures with a non-uniform dispersion of MW. The
combination of enzymatic methods with chemical strategies
(i.e., chemoenzymatic methods) offers a valuable alternative to
generate precision polysaccharides [399]. Synthetically pro
duced oligomers can be enzymatically polymerized to obtain
artificial polymers with well-defined branching pattern [7].
Being able to control the polysaccharide length remains the next
challenge. The inspiration could come from length-controlled
biosynthetic pathways [351,354,355].
Polymerization approaches allowed growing large synthetic
polysaccharides in short time and are easily scalable. However,
only few types of glycosidic linkages are accessible and mix
tures of different chain lengths are often generated. Recently re
ported methods for polymerization in confined space could
improve the control over the chain length [433-435].
Chemical synthesis enabled the preparation of well-defined
polysaccharides, but is labor-intensive, requiring several pro
tected monosaccharide BBs and, to date, it suffered from poor
scalability. Recently achieved total syntheses (i.e., 92mer [385]
and 128mer [325]) showed that long and well-defined polysac
charides could be accessed. With automated platforms, long
polysaccharides could be obtained routinely (i.e., 100mer and
151mer [278]), considerably reducing the lengthy synthetic
protocols traditionally needed for solution phase methods. Still,
only some classes of polysaccharides have been synthesized,
often relying on the relatively easy installation of 1,2-trans
glycosidic bonds. In contrast, the formation of multiple 1,2-cis
glycosidic bonds remains highly challenging. New highly selec
tive methods have been developed [167,178,285], however,
only few proved to be applicable to the synthesis of long poly
saccharides. Additionally, the low reactivity of particular BBs
(e.g., uronic acids for the synthesis of GAGs) hampered the
establishment of efficient synthetic protocols. A major limita
tion encountered in many reports of polysaccharide total synthe
sis is the decreased reactivity of large donors and acceptors.
This issue is, to date, poorly predictable, due to the little know
ledge on the conformation of protected glycans. Computational
methods are expected to help the understanding of the reactivi
ty for such complex molecules. While chemical ligation proto
cols enabled the total synthesis of proteins [436], similar
methods are still lacking for polysaccharides and fragment cou
pling often requires broad screenings of LGs, solvents, and acti
vation systems.
Aggregation is another major bottleneck that can drastically de
crease the yield of polysaccharide synthesis and can occur
either at the fully protected stage, during an intermediate stage
[156,157] (i.e., semiprotected stage) or at the final deprotected
stage [93,344].
Upon assembly of the protected polysaccharide target, either by
polymerization or chemical synthesis, the removal of the PGs
often proved to be challenging. Aggregation [93,156,157,437],
degradation (both during methanolysis [93] and hydrogenolysis
[294,325,326]), substituent migration [322,438] or cleavage are
among the most common issues encountered. The development
of better PGs that can be removed quantitatively is highly desir
able. Particular effort should be put towards the development of
novel N-PGs considering the many drawbacks of the currently
employed ones [251,261]. Novel PGs [439] and more suitable
solvent systems [440] could alleviate some of these problems.
The purification and characterization of long polysaccharides
poses an additional challenge, especially for ionic polysaccha
rides [398,441]. As the size of synthetic polysaccharides ap
proaches the size of macromolecules, the implementation of
novel analytical and purifications techniques becomes neces
sary [283].
Overall, structural precision has become an important goal in
polymer science as it is crucial to achieve novel properties or to
fully understand complex architectures [442,443]. Automated
techniques and solid-phase methods have become popular to
generate polymers with full control over the sequence, length,
and substitution [444,445]. These approaches, despite being
time consuming and in most cases not yet scalable, represent
the only amenable way to obtain structure–property correla
tions. Oligomers able to maintain the properties of longer poly
meric structures could become a valuable target to fill the gap
between small molecule and polymer science [446]. The same
trend is true for polysaccharides. Well-defined polysaccharides
could become essentials in biology where batch-to-batch repro
ducibility is imperative. Oligosaccharides with controlled
lengths will be required to induce particular biological
responses and automated techniques could grant access to
collection of pure compounds for screening. Full control on the
polysaccharide length and sequence will also be key to control
the aggregation of these compounds and create nanomaterials
with defined dimensions [447].
Funding
We thank the Max Planck Society, the MPG-FhG Cooperation
Project Glyco3Dysplay and the German Federal Ministry of
Education and Research (BMBF, grant number 13XP5114) for
generous financial support.
ORCID® iDs
Giulio Fittolani - https://orcid.org/0000-0001-6201-3454 Denisa Vargová - https://orcid.org/0000-0001-9923-7080 Manishkumar A. Chaube - https://orcid.org/0000-0001-9027-5275 Martina Delbianco - https://orcid.org/0000-0002-4580-9597


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2016
References
1. Varki, A.; Cummings, R. D.; Esko, J. D.; Stanley, P.; Hart, G. W.; Aebi, M.; Darvill, A. G.; Kinoshita, T.; Packer, N. H.; Prestegard, J. H.; Schnaar, R. L.; Seeberger, P. H. Essentials of Glycobiology, 3rd ed.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA, 2017. 2. de Moura, F. A.; Macagnan, F. T.; da Silva, L. P. Int. J. Food Sci. Technol. 2015, 50, 275–281. doi:10.1111/ijfs.12681 3. Verendel, J. J.; Church, T. L.; Andersson, P. G. Synthesis 2011, 1649–1677. doi:10.1055/s-0030-1260008 4. Guerrini, M.; Beccati, D.; Shriver, Z.; Naggi, A.; Viswanathan, K.; Bisio, A.; Capila, I.; Lansing, J. C.; Guglieri, S.; Fraser, B.; Al-Hakim, A.; Gunay, N. S.; Zhang, Z.; Robinson, L.; Buhse, L.; Nasr, M.; Woodcock, J.; Langer, R.; Venkataraman, G.; Linhardt, R. J.; Casu, B.; Torri, G.; Sasisekharan, R. Nat. Biotechnol. 2008, 26, 669–675. doi:10.1038/nbt1407 5. Anggara, K.; Zhu, Y.; Delbianco, M.; Rauschenbach, S.; Abb, S.; Seeberger, P. H.; Kern, K. J. Am. Chem. Soc. 2020, 142, 21420–21427. doi:10.1021/jacs.0c09933 6. Wu, X.; Delbianco, M.; Anggara, K.; Michnowicz, T.; Pardo-Vargas, A.; Bharate, P.; Sen, S.; Pristl, M.; Rauschenbach, S.; Schlickum, U.; Abb, S.; Seeberger, P. H.; Kern, K. Nature 2020, 582, 375–378. doi:10.1038/s41586-020-2362-1 7. Senf, D.; Ruprecht, C.; Kishani, S.; Matic, A.; Toriz, G.; Gatenholm, P.; Wågberg, L.; Pfrengle, F. Angew. Chem., Int. Ed. 2018, 57, 11987–11992. doi:10.1002/anie.201806871 8. Kittle, J. D.; Qian, C.; Edgar, E.; Roman, M.; Esker, A. R. ACS Omega 2018, 3, 14004–14012. doi:10.1021/acsomega.8b01750 9. Zhang, Q.; Gimeno, A.; Santana, D.; Wang, Z.; Valdés-Balbin, Y.; Rodríguez-Noda, L. M.; Hansen, T.; Kong, L.; Shen, M.; Overkleeft, H. S.; Vérez-Bencomo, V.; van der Marel, G. A.; Jiménez-Barbero, J.; Chiodo, F.; Codée, J. D. C. ACS Cent. Sci. 2019, 5, 1407–1416. doi:10.1021/acscentsci.9b00454 10. Armstrong, Z.; Withers, S. G. Biopolymers 2013, 99, 666–674. doi:10.1002/bip.22335 11. Smith, P. J.; Ortiz-Soto, M. E.; Roth, C.; Barnes, W. J.; Seibel, J.; Urbanowicz, B. R.; Pfrengle, F. ACS Sustainable Chem. Eng. 2020, 8, 11853–11871. doi:10.1021/acssuschemeng.0c03622 12. Perugino, G.; Cobucci-Ponzano, B.; Rossi, M.; Moracci, M. Adv. Synth. Catal. 2005, 347, 941–950. doi:10.1002/adsc.200505070 13. Kobayashi, S.; Uyama, H.; Kadokawa, J., Eds. Enzymatic
Polymerization towards Green Polymer Chemistry; Green Chemistry and Sustainable Technology; Springer International Publishing: Singapore, 2019. doi:10.1007/978-981-13-3813-7 14. Faijes, M.; Planas, A. Carbohydr. Res. 2007, 342, 1581–1594. doi:10.1016/j.carres.2007.06.015 15. Shoda, S.-i.; Uyama, H.; Kadokawa, J.-i.; Kimura, S.; Kobayashi, S. Chem. Rev. 2016, 116, 2307–2413. doi:10.1021/acs.chemrev.5b00472 16. Kobayashi, S.; Makino, A. Chem. Rev. 2009, 109, 5288–5353. doi:10.1021/cr900165z 17. Kadokawa, J.-i. Chem. Rev. 2011, 111, 4308–4345. doi:10.1021/cr100285v 18. Xiao, R.; Grinstaff, M. W. Prog. Polym. Sci. 2017, 74, 78–116. doi:10.1016/j.progpolymsci.2017.07.009 19. Mackenzie, L. F.; Wang, Q.; Warren, R. A. J.; Withers, S. G. J. Am. Chem. Soc. 1998, 120, 5583–5584. doi:10.1021/ja980833d 20. Danby, P. M.; Withers, S. G. ACS Chem. Biol. 2016, 11, 1784–1794. doi:10.1021/acschembio.6b00340
21. Hayes, M.; Pietruszka, J. Molecules 2017, 22, 1434. doi:10.3390/molecules22091434 22. Cobucci-Ponzano, B.; Moracci, M. Nat. Prod. Rep. 2012, 29, 697. doi:10.1039/c2np20032e 23. Wang, L.-X.; Huang, W. Curr. Opin. Chem. Biol. 2009, 13, 592–600. doi:10.1016/j.cbpa.2009.08.014 24. Adelwöhrer, C.; Takano, T.; Nakatsubo, F.; Rosenau, T. Biomacromolecules 2009, 10, 2817–2822. doi:10.1021/bm9006612 25. Tokatly, A. I.; Vinnitskiy, D. Z.; Ustuzhanina, N. E.; Nifantiev, N. E. Russ. J. Bioorg. Chem. 2021, 47, 53–70. doi:10.1134/s1068162021010258 26. Kaeothip, S.; Demchenko, A. V. Carbohydr. Res. 2011, 346, 1371–1388. doi:10.1016/j.carres.2011.05.004 27. Jeanneret, R. A.; Johnson, S. E.; Galan, M. C. J. Org. Chem. 2020. doi:10.1021/acs.joc.0c02045 28. Pardo-Vargas, A.; Delbianco, M.; Seeberger, P. H. Curr. Opin. Chem. Biol. 2018, 46, 48–55. doi:10.1016/j.cbpa.2018.04.007 29. Panza, M.; Pistorio, S. G.; Stine, K. J.; Demchenko, A. V. Chem. Rev. 2018, 118, 8105–8150. doi:10.1021/acs.chemrev.8b00051 30. Hsu, C.-H.; Hung, S.-C.; Wu, C.-Y.; Wong, C.-H. Angew. Chem., Int. Ed. 2011, 50, 11872–11923. doi:10.1002/anie.201100125 31. Panza, M.; Stine, K. J.; Demchenko, A. V. Chem. Commun. 2020, 56, 1333–1336. doi:10.1039/c9cc08876h 32. Seeberger, P. H. Acc. Chem. Res. 2015, 48, 1450–1463. doi:10.1021/ar5004362 33. Chang, C.-W.; Lin, M.-H.; Chan, C.-K.; Su, K.-Y.; Wu, C.-H.; Lo, W.-C.; Lam, S.; Cheng, Y.-T.; Liao, P.-H.; Wong, C.-H.; Wang, C.-C. Angew. Chem., Int. Ed. 2021, 60, 12413–12423. doi:10.1002/anie.202013909 34. van der Vorm, S.; Hansen, T.; Overkleeft, H. S.; van der Marel, G. A.; Codée, J. D. C. Chem. Sci. 2017, 8, 1867–1875. doi:10.1039/c6sc04638j
35. Crich, D. J. Am. Chem. Soc. 2021, 143, 17–34. doi:10.1021/jacs.0c11106 36. Fraser-Reid, B.; Cristóbal López, J., Eds. Reactivity Tuning in Oligosaccharide Assembly; Topics in Current Chemistry, Vol. 301; Springer: Berlin, Heidelberg, 2011. doi:10.1007/978-3-642-20914-7 37. Hettikankanamalage, A. A.; Lassfolk, R.; Ekholm, F. S.; Leino, R.; Crich, D. Chem. Rev. 2020, 120, 7104–7151. doi:10.1021/acs.chemrev.0c00243 38. Matsuzaki, Y.; Ito, Y.; Nakahara, Y.; Ogawa, T. Tetrahedron Lett. 1993, 34, 1061–1064. doi:10.1016/s0040-4039(00)77492-2 39. Petitou, M.; Duchaussoy, P.; Driguez, P.-A.; Hérault, J.-P.; Lormeau, J.-C.; Herbert, J.-M. Bioorg. Med. Chem. Lett. 1999, 9, 1155–1160. doi:10.1016/s0960-894x(99)00155-9
40. Pozsgay, V. Tetrahedron: Asymmetry 2000, 11, 151–172. doi:10.1016/s0957-4166(99)00553-4 41. Varki, A.; Cummings, R. D.; Aebi, M.; Packer, N. H.; Seeberger, P. H.; Esko, J. D.; Stanley, P.; Hart, G.; Darvill, A.; Kinoshita, T.; Prestegard, J. J.; Schnaar, R. L.; Freeze, H. H.; Marth, J. D.; Bertozzi, C. R.; Etzler, M. E.; Frank, M.; Vliegenthart, J. F.; Lütteke, T.; Perez, S.; Bolton, E.; Rudd, P.; Paulson, J.; Kanehisa, M.; Toukach, P.; Aoki-Kinoshita, K. F.; Dell, A.; Narimatsu, H.; York, W.; Taniguchi, N.; Kornfeld, S. Glycobiology 2015, 25, 1323–1324. doi:10.1093/glycob/cwv091


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2017
42. Rojas, O. J. In Cellulose Chemistry and Properties: Fibers, Nanocelluloses and Advanced Materials; Rojas, O. J., Ed.; Advances in Polymer Science, Vol. 271; Springer International Publishing: Cham, Switzerland, 2016. doi:10.1007/978-3-319-26015-0 43. O’Sullivan, A. C. Cellulose 1997, 4, 173–207. doi:10.1023/a:1018431705579 44. Atalla, R. H. Science 1998, 282, 591. doi:10.1126/science.282.5389.591a
45. Delmer, D. P. Annu. Rev. Plant Physiol. Plant Mol. Biol. 1999, 50, 245–276. doi:10.1146/annurev.arplant.50.1.245
46. Brown, R. M., Jr. J. Macromol. Sci., Part A: Pure Appl. Chem. 1996, 33, 1345–1373. doi:10.1080/10601329608014912 47. Rajinipriya, M.; Nagalakshmaiah, M.; Robert, M.; Elkoun, S. ACS Sustainable Chem. Eng. 2018, 6, 2807–2828. doi:10.1021/acssuschemeng.7b03437 48. Klemm, D.; Kramer, F.; Moritz, S.; Lindström, T.; Ankerfors, M.; Gray, D.; Dorris, A. Angew. Chem., Int. Ed. 2011, 50, 5438–5466. doi:10.1002/anie.201001273 49. Habibi, Y.; Lucia, L. A.; Rojas, O. J. Chem. Rev. 2010, 110, 3479–3500. doi:10.1021/cr900339w 50. Moon, R. J.; Martini, A.; Nairn, J.; Simonsen, J.; Youngblood, J. Chem. Soc. Rev. 2011, 40, 3941–3994. doi:10.1039/c0cs00108b 51. Thomas, B.; Raj, M. C.; B, A. K.; H, R. M.; Joy, J.; Moores, A.; Drisko, G. L.; Sanchez, C. Chem. Rev. 2018, 118, 11575–11625. doi:10.1021/acs.chemrev.7b00627 52. Schurz, J. Prog. Polym. Sci. 1999, 24, 481–483. doi:10.1016/s0079-6700(99)00011-8 53. Li, T.; Chen, C.; Brozena, A. H.; Zhu, J. Y.; Xu, L.; Driemeier, C.; Dai, J.; Rojas, O. J.; Isogai, A.; Wågberg, L.; Hu, L. Nature 2021, 590, 47–56. doi:10.1038/s41586-020-03167-7 54. Serizawa, T.; Fukaya, Y.; Sawada, T. Polym. J. 2018, 50, 799–804. doi:10.1038/s41428-018-0057-3 55. Burchard, W. Cellulose 2003, 10, 213–225. doi:10.1023/a:1025160620576 56. Potthast, A.; Rosenau, T.; Buchner, R.; Röder, T.; Ebner, G.; Bruglachner, H.; Sixta, H.; Kosma, P. Cellulose 2002, 9, 41–53. doi:10.1023/a:1015811712657 57. Kostag, M.; Gericke, M.; Heinze, T.; El Seoud, O. A. Cellulose 2019, 26, 139–184. doi:10.1007/s10570-018-2198-0
58. Kobayashi, S. J. Polym. Sci., Part A: Polym. Chem. 2005, 43, 693–710. doi:10.1002/pola.20662 59. Billès, E.; Coma, V.; Peruch, F.; Grelier, S. Polym. Int. 2017, 66, 1227–1236. doi:10.1002/pi.5398 60. Nidetzky, B.; Zhong, C. Biotechnol. Adv. 2020, 107633. doi:10.1016/j.biotechadv.2020.107633 61. Kobayashi, S.; Kashiwa, K.; Kawasaki, T.; Shoda, S.-i. J. Am. Chem. Soc. 1991, 113, 3079–3084. doi:10.1021/ja00008a042 62. Hiraishi, M.; Igarashi, K.; Kimura, S.; Wada, M.; Kitaoka, M.; Samejima, M. Carbohydr. Res. 2009, 344, 2468–2473. doi:10.1016/j.carres.2009.10.002 63. Hattori, T.; Ogata, M.; Kameshima, Y.; Totani, K.; Nikaido, M.; Nakamura, T.; Koshino, H.; Usui, T. Carbohydr. Res. 2012, 353, 22–26. doi:10.1016/j.carres.2012.03.018 64. Lee, J. H.; Brown, R. M.; Kuga, S.; Shoda, S.-i.; Kobayashi, S. Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 7425–7429. doi:10.1073/pnas.91.16.7425 65. Pylkkänen, R.; Mohammadi, P.; Arola, S.; de Ruijter, J. C.; Sunagawa, N.; Igarashi, K.; Penttilä, M. Biomacromolecules 2020, 21, 4355–4364. doi:10.1021/acs.biomac.0c01162
66. Hata, Y.; Sawada, T.; Marubayashi, H.; Nojima, S.; Serizawa, T. Langmuir 2019, 35, 7026–7034. doi:10.1021/acs.langmuir.9b00850 67. Yataka, Y.; Sawada, T.; Serizawa, T. Langmuir 2016, 32, 10120–10125. doi:10.1021/acs.langmuir.6b02679 68. Serizawa, T.; Fukaya, Y.; Sawada, T. Langmuir 2017, 33, 13415–13422. doi:10.1021/acs.langmuir.7b03653 69. Hata, Y.; Kojima, T.; Koizumi, T.; Okura, H.; Sakai, T.; Sawada, T.; Serizawa, T. ACS Macro Lett. 2017, 6, 165–170. doi:10.1021/acsmacrolett.6b00848 70. Hashimoto, T.; Tanaka, H.; Koizumi, S.; Kurosaki, K.; Ohmae, M.; Kobayashi, S. Biomacromolecules 2006, 7, 2479–2482. doi:10.1021/bm0605255 71. Tanaka, H.; Koizumi, S.; Hashimoto, T.; Kurosaki, K.; Kobayashi, S. Macromolecules 2007, 40, 6304–6315. doi:10.1021/ma070699u 72. Egusa, S.; Kitaoka, T.; Goto, M.; Wariishi, H. Angew. Chem., Int. Ed. 2007, 46, 2063–2065. doi:10.1002/anie.200603981 73. Egusa, S.; Kitaoka, T.; Igarashi, K.; Samejima, M.; Goto, M.; Wariishi, H. J. Mol. Catal. B: Enzym. 2010, 67, 225–230. doi:10.1016/j.molcatb.2010.08.010 74. Egusa, S.; Goto, M.; Kitaoka, T. Biomacromolecules 2012, 13, 2716–2722. doi:10.1021/bm3006775 75. Nakamura, I.; Makino, A.; Sugiyama, J.; Ohmae, M.; Kimura, S. Int. J. Biol. Macromol. 2008, 43, 226–231. doi:10.1016/j.ijbiomac.2008.05.007 76. Nakamura, I.; Makino, A.; Horikawa, Y.; Sugiyama, J.; Ohmae, M.; Kimura, S. Chem. Commun. 2011, 47, 10127–10129. doi:10.1039/c1cc14202j 77. Nakamura, I.; Horikawa, Y.; Makino, A.; Sugiyama, J.; Kimura, S. Biomacromolecules 2011, 12, 785–790. doi:10.1021/bm101394j 78. Andrade, P.; Muñoz‐García, J. C.; Pergolizzi, G.; Gabrielli, V.; Nepogodiev, S. A.; Iuga, D.; Fábián, L.; Nigmatullin, R.; Johns, M. A.; Harniman, R.; Eichhorn, S. J.; Angulo, J.; Khimyak, Y. Z.; Field, R. A. Chem. – Eur. J. 2021, 27, 1374–1382. doi:10.1002/chem.202003604 79. Serizawa, T.; Kato, M.; Okura, H.; Sawada, T.; Wada, M. Polym. J. 2016, 48, 539–544. doi:10.1038/pj.2015.125 80. Fujita, M.; Shoda, S.-i.; Kobayashi, S. J. Am. Chem. Soc. 1998, 120, 6411–6412. doi:10.1021/ja980893j 81. Kobayashi, S.; Makino, A.; Matsumoto, H.; Kunii, S.; Ohmae, M.; Kiyosada, T.; Makiguchi, K.; Matsumoto, A.; Horie, M.; Shoda, S.-I. Biomacromolecules 2006, 7, 1644–1656. doi:10.1021/bm060094q 82. Codera, V.; Edgar, K. J.; Faijes, M.; Planas, A. Biomacromolecules 2016, 17, 1272–1279. doi:10.1021/acs.biomac.5b01453 83. Nakatsubo, F.; Kamitakahara, H.; Hori, M. J. Am. Chem. Soc. 1996, 118, 1677–1681. doi:10.1021/ja953286u 84. Kamitakahara, H.; Hori, M.; Nakatsubo, F. Macromolecules 1996, 29, 6126–6131. doi:10.1021/ma960488h 85. Hori, M.; Nakatsubo, F. Macromolecules 2001, 34, 2476–2481. doi:10.1021/ma001652a 86. Yagura, T.; Ikegami, W.; Kamitakahara, H.; Takano, T. Cellulose 2020, 27, 9755–9766. doi:10.1007/s10570-020-03512-z 87. Kamitakahara, H.; Funakoshi, T.; Nakai, S.; Takano, T.; Nakatsubo, F. Cellulose 2009, 16, 1179–1185. doi:10.1007/s10570-009-9339-4 88. Kamitakahara, H.; Funakoshi, T.; Takano, T.; Nakatsubo, F. Cellulose 2009, 16, 1167–1178. doi:10.1007/s10570-009-9332-y 89. Sakakibara, K.; Takano, T.; Nakatsubo, F. Cellulose 2011, 18, 105–115. doi:10.1007/s10570-010-9461-3 90. Karakawa, M.; Kamitakahara, H.; Takano, T.; Nakatsubo, F. Biomacromolecules 2002, 3, 538–546. doi:10.1021/bm015656e 91. Nishimura, T.; Nakatsubo, F. Cellulose 1997, 4, 109–130. doi:10.1023/a:1018423503762


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2018
92. Nishimura, T.; Nakatsubo, F. Tetrahedron Lett. 1996, 37, 9215–9218. doi:10.1016/s0040-4039(96)02186-7 93. Yu, Y.; Tyrikos‐Ergas, T.; Zhu, Y.; Fittolani, G.; Bordoni, V.; Singhal, A.; Fair, R. J.; Grafmüller, A.; Seeberger, P. H.; Delbianco, M. Angew. Chem., Int. Ed. 2019, 58, 13127–13132. doi:10.1002/anie.201906577 94. Murty, K. V. S. N.; Xie, T.; Bernet, B.; Vasella, A. Helv. Chim. Acta 2006, 89, 675–730. doi:10.1002/hlca.200690068 95. Hayashi, T.; Marsden, M. P. F.; Delmer, D. P. Plant Physiol. 1987, 83, 384–389. doi:10.1104/pp.83.2.384 96. Kuki, H.; Yokoyama, R.; Kuroha, T.; Nishitani, K. Plants 2020, 9, 629. doi:10.3390/plants9050629 97. Culbertson, A. T.; Ehrlich, J. J.; Choe, J.-Y.; Honzatko, R. B.;
Zabotina, O. A. Proc. Natl. Acad. Sci. U. S. A. 2018, 115, 6064–6069. doi:10.1073/pnas.1801105115 98. Urbanowicz, B. R.; Bharadwaj, V. S.; Alahuhta, M.; Peña, M. J.; Lunin, V. V.; Bomble, Y. J.; Wang, S.; Yang, J.-Y.; Tuomivaara, S. T.; Himmel, M. E.; Moremen, K. W.; York, W. S.; Crowley, M. F. Plant J. 2017, 91, 931–949. doi:10.1111/tpj.13628 99. Kinnaert, C.; Daugaard, M.; Nami, F.; Clausen, M. H. Chem. Rev. 2017, 117, 11337–11405. doi:10.1021/acs.chemrev.7b00162 100.Fry, S. C.; York, W. S.; Albersheim, P.; Darvill, A.; Hayashi, T.; Joseleau, J.-P.; Kato, Y.; Lorences, E. P.; Maclachlan, G. A.; McNeil, M.; Mort, A. J.; Grant Reid, J. S.; Seitz, H. U.; Selvendran, R. R.; Voragen, A. G. J.; White, A. R. Physiol. Plant. 1993, 89, 1–3. doi:10.1111/j.1399-3054.1993.tb01778.x 101.Sakai, K.; Nakahara, Y.; Ogawa, T. Tetrahedron Lett. 1990, 31, 3035–3038. doi:10.1016/s0040-4039(00)89019-x 102.Bartetzko, M. P.; Pfrengle, F. ChemBioChem 2019, 20, 877–885. doi:10.1002/cbic.201800641 103.Dallabernardina, P.; Schuhmacher, F.; Seeberger, P. H.; Pfrengle, F. Org. Biomol. Chem. 2016, 14, 309–313. doi:10.1039/c5ob02226f 104.Dallabernardina, P.; Ruprecht, C.; Smith, P. J.; Hahn, M. G.; Urbanowicz, B. R.; Pfrengle, F. Org. Biomol. Chem. 2017, 15, 9996–10000. doi:10.1039/c7ob02605f 105.Fauré, R.; Saura-Valls, M.; Brumer, H.; Planas, A.; Cottaz, S.; Driguez, H. J. Org. Chem. 2006, 71, 5151–5161. doi:10.1021/jo0525682 106.Fauré, R.; Cavalier, D.; Keegstra, K.; Cottaz, S.; Driguez, H. Eur. J. Org. Chem. 2007, 4313–4319. doi:10.1002/ejoc.200700395 107.Piens, K.; Henriksson, A.-M.; Gullfot, F.; Lopez, M.; Fauré, R.; Ibatullin, F. M.; Teeri, T. T.; Driguez, H.; Brumer, H. Org. Biomol. Chem. 2007, 5, 3971–3978. doi:10.1039/b714570e 108.Lopez, M.; Fort, S.; Bizot, H.; Buléon, A.; Driguez, H. Carbohydr. Polym. 2012, 88, 185–193. doi:10.1016/j.carbpol.2011.11.085 109.Gullfot, F.; Ibatullin, F. M.; Sundqvist, G.; Davies, G. J.; Brumer, H. Biomacromolecules 2009, 10, 1782–1788. doi:10.1021/bm900215p 110.Spadiut, O.; Ibatullin, F. M.; Peart, J.; Gullfot, F.; Martinez-Fleites, C.; Ruda, M.; Xu, C.; Sundqvist, G.; Davies, G. J.; Brumer, H. J. Am. Chem. Soc. 2011, 133, 10892–10900. doi:10.1021/ja202788q 111.Descroix, K.; Ferrieres, V.; Jamois, F.; Yvin, J.-C.; Plusquellec, D. Mini-Rev. Med. Chem. 2006, 6, 1341–1349. doi:10.2174/138955706778993058 112.Ogawa, Y.; Noda, K.; Kimura, S.; Kitaoka, M.; Wada, M. Int. J. Biol. Macromol. 2014, 64, 415–419. doi:10.1016/j.ijbiomac.2013.12.027 113.Elsaidi, H. R. H.; Paszkiewicz, E.; Bundle, D. R. Carbohydr. Res. 2015, 408, 96–106. doi:10.1016/j.carres.2015.03.007
114.Adamo, R.; Hu, Q.-Y.; Torosantucci, A.; Crotti, S.; Brogioni, G.; Allan, M.; Chiani, P.; Bromuro, C.; Quinn, D.; Tontini, M.; Berti, F. Chem. Sci. 2014, 5, 4302–4311. doi:10.1039/c4sc01361a 115.Adamo, R.; Tontini, M.; Brogioni, G.; Romano, M. R.; Costantini, G.; Danieli, E.; Proietti, D.; Berti, F.; Costantino, P. J. Carbohydr. Chem. 2011, 30, 249–280. doi:10.1080/07328303.2011.604453 116.Huang, G.-L.; Mei, X.-Y.; Liu, M.-X. Carbohydr. Res. 2005, 340, 603–608. doi:10.1016/j.carres.2005.01.015 117.Huang, G.-L.; Mei, X.-Y.; Liu, M.-X.; Liu, T.-C. Bioorg. Med. Chem. Lett. 2004, 14, 6027–6029. doi:10.1016/j.bmcl.2004.09.076 118.Le Mai Hoang, K.; Pardo-Vargas, A.; Zhu, Y.; Yu, Y.; Loria, M.; Delbianco, M.; Seeberger, P. H. J. Am. Chem. Soc. 2019, 141, 9079–9086. doi:10.1021/jacs.9b03769 119.Yashunsky, D. V.; Tsvetkov, Y. E.; Nifantiev, N. E. Carbohydr. Res. 2016, 436, 25–30. doi:10.1016/j.carres.2016.11.005 120.Yang, G.; Kong, F. Carbohydr. Res. 2005, 340, 39–48. doi:10.1016/j.carres.2004.11.005 121.Zhao, W.; Yang, G.; Kong, F. Carbohydr. Res. 2003, 338, 2813–2823. doi:10.1016/j.carres.2003.08.003 122.Zeng, Y.; Kong, F. Carbohydr. Res. 2003, 338, 2359–2366. doi:10.1016/j.carres.2003.08.004 123.Tanaka, H.; Amaya, T.; Takahashi, T. Tetrahedron Lett. 2003, 44, 3053–3057. doi:10.1016/s0040-4039(03)00553-7 124.Yang, G.; Kong, F. Synlett 2000, 1423–1426. doi:10.1055/s-2000-7646 125.Egusa, K.; Kusumoto, S.; Fukase, K. Eur. J. Org. Chem. 2003, 3435–3445. doi:10.1002/ejoc.200300248 126.Yashunsky, D. V.; Tsvetkov, Y. E.; Grachev, A. A.; Chizhov, A. O.; Nifantiev, N. E. Carbohydr. Res. 2016, 419, 8–17. doi:10.1016/j.carres.2015.10.012 127.Yang, F.; He, H.; Du, Y.; Lü, M. Carbohydr. Res. 2002, 337, 1165–1169. doi:10.1016/s0008-6215(02)00122-2 128.Ning, J.; Zhang, W.; Yi, Y.; Yang, G.; Wu, Z.; Yi, J.; Kong, F. Bioorg. Med. Chem. 2003, 11, 2193–2203. doi:10.1016/s0968-0896(03)00118-4 129.Zeng, Y.; Ning, J.; Kong, F. Tetrahedron Lett. 2002, 43, 3729–3733. doi:10.1016/s0040-4039(02)00584-1 130.Yu, H.; Williams, D. L.; Ensley, H. E. Tetrahedron Lett. 2005, 46, 3417–3421. doi:10.1016/j.tetlet.2005.03.099 131.He, H.; Yang, F.; Du, Y. Carbohydr. Res. 2002, 337, 1673–1678. doi:10.1016/s0008-6215(02)00276-8 132.Takeo, K.; Maki, K.; Wada, Y.; Kitamura, S. Carbohydr. Res. 1993, 245, 81–96. doi:10.1016/0008-6215(93)80061-i 133.Jamois, F.; Ferrières, V.; Guégan, J.-P.; Yvin, J.-C.; Plusquellec, D.; Vetvicka, V. Glycobiology 2005, 15, 393–407. doi:10.1093/glycob/cwi020 134.Mo, K.-F.; Li, H.; Mague, J. T.; Ensley, H. E. Carbohydr. Res. 2009, 344, 439–447. doi:10.1016/j.carres.2008.12.014 135.Liao, G.; Zhou, Z.; Burgula, S.; Liao, J.; Yuan, C.; Wu, Q.; Guo, Z. Bioconjugate Chem. 2015, 26, 466–476. doi:10.1021/bc500575a 136.Liao, G.; Burgula, S.; Zhou, Z.; Guo, Z. Eur. J. Org. Chem. 2015, 2942–2951. doi:10.1002/ejoc.201500229 137.Tanaka, H.; Kawai, T.; Adachi, Y.; Hanashima, S.; Yamaguchi, Y.; Ohno, N.; Takahashi, T. Bioorg. Med. Chem. 2012, 20, 3898–3914. doi:10.1016/j.bmc.2012.04.017 138.Tanaka, H.; Kawai, T.; Adachi, Y.; Ohno, N.; Takahashi, T. Chem. Commun. 2010, 46, 8249–8251. doi:10.1039/c0cc03153d 139.Hamagami, H.; Adachi, Y.; Ohno, N.; Tanaka, H. Asian J. Org. Chem. 2019, 8, 411–416. doi:10.1002/ajoc.201800726


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2019
140.Weishaupt, M. W.; Hahm, H. S.; Geissner, A.; Seeberger, P. H. Chem. Commun. 2017, 53, 3591–3594. doi:10.1039/c7cc00520b 141.Weishaupt, M. W.; Matthies, S.; Seeberger, P. H. Chem. – Eur. J. 2013, 19, 12497–12503. doi:10.1002/chem.201204518 142.Plante, O. J.; Palmacci, E. R.; Seeberger, P. H. Science 2001, 291, 1523–1527. doi:10.1126/science.1057324 143.Dallabernardina, P.; Schuhmacher, F.; Seeberger, P. H.; Pfrengle, F. Chem. – Eur. J. 2017, 23, 3191–3196. doi:10.1002/chem.201605479 144.Fairweather, J. K.; Hrmova, M.; Rutten, S. J.; Fincher, G. B.; Driguez, H. Chem. – Eur. J. 2003, 9, 2603–2610. doi:10.1002/chem.200304733 145.Montel, E.; Hrmova, M.; Fincher, G. B.; Driguez, H.; Cottaz, S. Aust. J. Chem. 2009, 62, 575. doi:10.1071/ch08517 146.Hrmova, M.; Imai, T.; Rutten, S. J.; Fairweather, J. K.; Pelosi, L.; Bulone, V.; Driguez, H.; Fincher, G. B. J. Biol. Chem. 2002, 277, 30102–30111. doi:10.1074/jbc.m203971200 147.Perez, X.; Faijes, M.; Planas, A. Biomacromolecules 2011, 12, 494–501. doi:10.1021/bm1013537 148.Yashunsky, D. V.; Karelin, A. A.; Tsvetkov, Y. E.; Nifantiev, N. E. Carbohydr. Res. 2018, 455, 18–22. doi:10.1016/j.carres.2017.11.001 149.Wang, H.-R.; Li, Z.-L.; Ning, J.; Kong, F.-Z. Chin. J. Chem. 2003, 21, 944–949. doi:10.1002/cjoc.20030210744 150.Sittel, I.; Tran, A.-T.; Benito-Alifonso, D.; Galan, M. C. Chem. Commun. 2013, 49, 4217–4219. doi:10.1039/c2cc37164b 151.Manmode, S.; Kato, M.; Ichiyanagi, T.; Nokami, T.; Itoh, T. Asian J. Org. Chem. 2018, 7, 1802–1805. doi:10.1002/ajoc.201800345 152.Smith, R.; Müller-Bunz, H.; Zhu, X. Org. Lett. 2016, 18, 3578–3581. doi:10.1021/acs.orglett.6b01572 153.Pistorio, S. G.; Nigudkar, S. S.; Stine, K. J.; Demchenko, A. V. J. Org. Chem. 2016, 81, 8796–8805. doi:10.1021/acs.joc.6b01439 154.Huang, X.; Huang, L.; Wang, H.; Ye, X.-S. Angew. Chem., Int. Ed. 2004, 43, 5221–5224. doi:10.1002/anie.200460176 155.Hashihayata, T.; Ikegai, K.; Takeuchi, K.; Jona, H.; Mukaiyama, T. Bull. Chem. Soc. Jpn. 2003, 76, 1829–1848. doi:10.1246/bcsj.76.1829 156.Yu, Y.; Gim, S.; Kim, D.; Arnon, Z. A.; Gazit, E.; Seeberger, P. H.; Delbianco, M. J. Am. Chem. Soc. 2019, 141, 4833–4838. doi:10.1021/jacs.8b11882 157.Delbianco, M.; Kononov, A.; Poveda, A.; Yu, Y.; Diercks, T.; Jiménez-Barbero, J.; Seeberger, P. H. J. Am. Chem. Soc. 2018, 140, 5421–5426. doi:10.1021/jacs.8b00254 158.Yi, Y.; Zhou, Z.; Ning, J.; Kong, F.; Li, J. Synthesis 2003, 0491–0496. doi:10.1055/s-2003-37644 159.Tanaka, H.; Adachi, M.; Tsukamoto, H.; Ikeda, T.; Yamada, H.; Takahashi, T. Org. Lett. 2002, 4, 4213–4216. doi:10.1021/ol020150+ 160.Nicolaou, K. C.; Winssinger, N.; Pastor, J.; DeRoose, F. J. Am. Chem. Soc. 1997, 119, 449–450. doi:10.1021/ja963482g 161.Yamada, H.; Harada, T.; Takahashi, T. J. Am. Chem. Soc. 1994, 116, 7919–7920. doi:10.1021/ja00096a068 162.Fügedi, P.; Birberg, W.; Garegg, P. J.; Pilotti, Å. Carbohydr. Res. 1987, 164, 297–312. doi:10.1016/0008-6215(87)80137-4 163.Ossowski, P.; Pilotti, A.; Garegg, P. J.; Lindberg, B. J. Biol. Chem. 1984, 259, 11337–11340. doi:10.1016/s0021-9258(18)90866-5 164.Ossowski, P.; Pilotti, Å.; Garegg, P. J.; Lindberg, B. Angew. Chem., Int. Ed. Engl. 1983, 22, 793–794. doi:10.1002/anie.198307931 165.Ning, J.; Yi, Y.; Kong, F. Tetrahedron Lett. 2002, 43, 5545–5549. doi:10.1016/s0040-4039(02)01143-7
166.Nicolaou, K. C.; Watanabe, N.; Li, J.; Pastor, J.; Winssinger, N. Angew. Chem., Int. Ed. 1998, 37, 1559–1561.
doi:10.1002/(sici)1521-3773(19980619)37:11<1559::aid-anie1559>3.0 .co;2-e 167.Nigudkar, S. S.; Demchenko, A. V. Chem. Sci. 2015, 6, 2687–2704. doi:10.1039/c5sc00280j 168.Geoghegan, I.; Steinberg, G.; Gurr, S. Trends Microbiol. 2017, 25, 957–967. doi:10.1016/j.tim.2017.05.015 169.Komarova, B. S.; Orekhova, M. V.; Tsvetkov, Y. E.; Beau, R.; Aimanianda, V.; Latgé, J.-P.; Nifantiev, N. E. Chem. – Eur. J. 2015, 21, 1029–1035. doi:10.1002/chem.201404770 170.Komarova, B. S.; Tsvetkov, Y. E.; Nifantiev, N. E. Chem. Rec. 2016, 16, 488–506. doi:10.1002/tcr.201500245 171.Hahm, H. S.; Hurevich, M.; Seeberger, P. H. Nat. Commun. 2016, 7, 12482. doi:10.1038/ncomms12482 172.Hirooka, M.; Koto, S. Bull. Chem. Soc. Jpn. 1998, 71, 2893–2902. doi:10.1246/bcsj.71.2893 173.Lam, S. N.; Gervay-Hague, J. Carbohydr. Res. 2002, 337, 1953–1965. doi:10.1016/s0008-6215(02)00227-6 174.Boltje, T. J.; Kim, J.-H.; Park, J.; Boons, G.-J. Nat. Chem. 2010, 2, 552–557. doi:10.1038/nchem.663 175.Tomita, S.; Tanaka, M.; Inoue, M.; Inaba, K.; Takahashi, D.; Toshima, K. J. Org. Chem. 2020, 85, 16254–16262. doi:10.1021/acs.joc.0c02093 176.Tanaka, M.; Nakagawa, A.; Nishi, N.; Iijima, K.; Sawa, R.; Takahashi, D.; Toshima, K. J. Am. Chem. Soc. 2018, 140, 3644–3651. doi:10.1021/jacs.7b12108 177.Yasomanee, J. P.; Demchenko, A. V. Angew. Chem., Int. Ed. 2014, 53, 10453–10456. doi:10.1002/anie.201405084 178.Wang, L.; Overkleeft, H. S.; van der Marel, G. A.; Codée, J. D. C. J. Am. Chem. Soc. 2018, 140, 4632–4638. doi:10.1021/jacs.8b00669 179.Wang, L.; Overkleeft, H. S.; van der Marel, G. A.; Codée, J. D. C. Eur. J. Org. Chem. 2019, 1994–2003. doi:10.1002/ejoc.201800894 180.Wang, L.; Berni, F.; Enotarpi, J.; Overkleeft, H. S.; van der Marel, G.; Codée, J. D. C. Org. Biomol. Chem. 2020, 18, 2038–2050. doi:10.1039/d0ob00240b 181.Zhang, Y.; He, H.; Chen, Z.; Huang, Y.; Xiang, G.; Li, P.; Yang, X.; Lu, G.; Xiao, G. Angew. Chem., Int. Ed. 2021, 60, 12597–12606. doi:10.1002/anie.202103826 182.Zhu, Y.; Delbianco, M.; Seeberger, P. H. J. Am. Chem. Soc. 2021, 143, 9758–9768. doi:10.1021/jacs.1c02188 183.Meppen, M.; Wang, Y.; Cheon, H.-S.; Kishi, Y. J. Org. Chem. 2007, 72, 1941–1950. doi:10.1021/jo061990v 184.Cheon, H.-S.; Lian, Y.; Kishi, Y. Org. Lett. 2007, 9, 3327–3329. doi:10.1021/ol071334x 185.Ohdan, K.; Fujii, K.; Yanase, M.; Takaha, T.; Kuriki, T. Biocatal. Biotransform. 2006, 24, 77–81. doi:10.1080/10242420600598152 186.Nishimura, T.; Akiyoshi, K.
Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2017, 9, e1423. doi:10.1002/wnan.1423 187.Meng, X.; Pijning, T.; Dobruchowska, J. M.; Yin, H.; Gerwig, G. J.; Dijkhuizen, L. Sci. Rep. 2016, 6, 35261. doi:10.1038/srep35261 188.Meng, X.; Dobruchowska, J. M.; Gerwig, G. J.; Kamerling, J. P.; Dijkhuizen, L. Carbohydr. Res. 2015, 414, 85–92. doi:10.1016/j.carres.2015.07.011 189.Timell, T. E. Adv. Carbohydr. Chem. 1964, 19, 247–302. doi:10.1016/s0096-5332(08)60284-2


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2020
190.Thorsheim, K.; Siegbahn, A.; Johnsson, R. E.; Stålbrand, H.; Manner, S.; Widmalm, G.; Ellervik, U. Carbohydr. Res. 2015, 418, 65–88. doi:10.1016/j.carres.2015.10.004 191.Ebringerová, A.; Heinze, T. Macromol. Rapid Commun. 2000, 21, 542–556. doi:10.1002/1521-3927(20000601)21:9<542::aid-marc542>3.0.co;2-7 192.Busse-Wicher, M.; Grantham, N. J.; Lyczakowski, J. J.; Nikolovski, N.; Dupree, P. Biochem. Soc. Trans. 2016, 44, 74–78. doi:10.1042/bst20150183 193.Grantham, N. J.; Wurman-Rodrich, J.; Terrett, O. M.; Lyczakowski, J. J.; Stott, K.; Iuga, D.; Simmons, T. J.; Durand-Tardif, M.; Brown, S. P.; Dupree, R.; Busse-Wicher, M.; Dupree, P. Nat. Plants (London, U. K.) 2017, 3, 859–865. doi:10.1038/s41477-017-0030-8 194.Santibáñez, L.; Henríquez, C.; Corro-Tejeda, R.; Bernal, S.; Armijo, B.; Salazar, O. Carbohydr. Polym. 2021, 251, 117118. doi:10.1016/j.carbpol.2020.117118 195.Köhnke, T.; Östlund, Å.; Brelid, H. Biomacromolecules 2011, 12, 2633–2641. doi:10.1021/bm200437m 196.Bosmans, T. J.; Stépán, A. M.; Toriz, G.; Renneckar, S.; Karabulut, E.; Wågberg, L.; Gatenholm, P. Biomacromolecules 2014, 15, 924–930. doi:10.1021/bm4017868 197.Linder, Å.; Bergman, R.; Bodin, A.; Gatenholm, P. Langmuir 2003, 19, 5072–5077. doi:10.1021/la0341355 198.Timell, T. E. J. Am. Chem. Soc. 1959, 81, 4989–4994. doi:10.1021/ja01527a054 199.Uryu, T.; Koyama, Y.; Matsuzaki, K. J. Polym. Sci., Polym. Lett. Ed. 1979, 17, 673–678. doi:10.1002/pol.1979.130171009 200.Uryu, T.; Koyama, Y.; Matsuzaki, K. Makromol. Chem. 1984, 185, 2099–2107. doi:10.1002/macp.1984.021851005 201.Uryu, T.; Yamanouchi, J.; Hayashi, S.; Tamaki, H.; Matsuzaki, K. Macromolecules 1983, 16, 320–326. doi:10.1021/ma00236a030 202.Kim, Y.-W.; Fox, D. T.; Hekmat, O.; Kantner, T.; McIntosh, L. P.; Warren, R. A. J.; Withers, S. G. Org. Biomol. Chem. 2006, 4, 2025. doi:10.1039/b601667g 203.Kobayashi, S.; Wen, X.; Shoda, S.-i. Macromolecules 1996, 29, 2698–2700. doi:10.1021/ma951552i 204.Ben-David, A.; Bravman, T.; Balazs, Y. S.; Czjzek, M.; Schomburg, D.; Shoham, G.; Shoham, Y. ChemBioChem 2007, 8, 2145–2151. doi:10.1002/cbic.200700414 205.Takeo, K.; Ohguchi, Y.; Hasegawa, R.; Kitamura, S. Carbohydr. Res. 1995, 278, 301–313. doi:10.1016/0008-6215(95)00259-6 206.Chen, L.; Kong, F. Carbohydr. Res. 2002, 337, 2335–2341. doi:10.1016/s0008-6215(02)00285-9 207.Schmidt, D.; Schuhmacher, F.; Geissner, A.; Seeberger, P. H.; Pfrengle, F. Chem. – Eur. J. 2015, 21, 5709–5713. doi:10.1002/chem.201500065 208.Senf, D.; Ruprecht, C.; de Kruijff, G. H. M.; Simonetti, S. O.; Schuhmacher, F.; Seeberger, P. H.; Pfrengle, F. Chem. – Eur. J. 2017, 23, 3197–3205. doi:10.1002/chem.201605902 209.Khoushab, F.; Yamabhai, M. Mar. Drugs 2010, 8, 1988–2012. doi:10.3390/md8071988 210.Kurita, K. Mar. Biotechnol. 2006, 8, 203–226. doi:10.1007/s10126-005-0097-5 211.Rinaudo, M. Prog. Polym. Sci. 2006, 31, 603–632. doi:10.1016/j.progpolymsci.2006.06.001 212.Azuma, K.; Izumi, R.; Osaki, T.; Ifuku, S.; Morimoto, M.; Saimoto, H.; Minami, S.; Okamoto, Y. J. Funct. Biomater. 2015, 6, 104–142. doi:10.3390/jfb6010104
213.Xu, H.; Shen, B.; Qiao, M.; Linhardt, R. J.; Zhang, X. Carbohydr. Polym. 2021, 258, 117672. doi:10.1016/j.carbpol.2021.117672 214.Shoueir, K. R.; El-Desouky, N.; Rashad, M. M.; Ahmed, M. K.; Janowska, I.; El-Kemary, M. Int. J. Biol. Macromol. 2021, 167, 1176–1197. doi:10.1016/j.ijbiomac.2020.11.072 215.Bonin, M.; Sreekumar, S.; Cord-Landwehr, S.; Moerschbacher, B. M. Int. J. Mol. Sci. 2020, 21, 7835. doi:10.3390/ijms21217835 216.Naqvi, S.; Moerschbacher, B. M. Crit. Rev. Biotechnol. 2017, 37, 11–25. doi:10.3109/07388551.2015.1104289 217.Yang, Y.; Yu, B. Tetrahedron 2014, 70, 1023–1046. doi:10.1016/j.tet.2013.11.064 218.Wattjes, J.; Sreekumar, S.; Richter, C.; Cord-Landwehr, S.; Singh, R.; El Gueddari, N. E.; Moerschbacher, B. M. React. Funct. Polym. 2020, 151, 104583. doi:10.1016/j.reactfunctpolym.2020.104583 219.Cord-Landwehr, S.; Richter, C.; Wattjes, J.; Sreekumar, S.; Singh, R.; Basa, S.; El Gueddari, N. E.; Moerschbacher, B. M. React. Funct. Polym. 2020, 151, 104577. doi:10.1016/j.reactfunctpolym.2020.104577 220.Fuchs, K.; Cardona Gloria, Y.; Wolz, O.-O.; Herster, F.; Sharma, L.; Dillen, C. A.; Täumer, C.; Dickhöfer, S.; Bittner, Z.; Dang, T.-M.; Singh, A.; Haischer, D.; Schlöffel, M. A.; Koymans, K. J.; Sanmuganantham, T.; Krach, M.; Roger, T.; Le Roy, D.; Schilling, N. A.; Frauhammer, F.; Miller, L. S.; Nürnberger, T.; LeibundGut‐Landmann, S.; Gust, A. A.; Macek, B.; Frank, M.; Gouttefangeas, C.; Dela Cruz, C. S.; Hartl, D.; Weber, A. N. EMBO Rep. 2018, 19, e46065. doi:10.15252/embr.201846065 221.Basa, S.; Nampally, M.; Honorato, T.; Das, S. N.; Podile, A. R.; El Gueddari, N. E.; Moerschbacher, B. M. J. Am. Chem. Soc. 2020, 142, 1975–1986. doi:10.1021/jacs.9b11466 222.Osorio-Madrazo, A.; David, L.; Trombotto, S.; Lucas, J.-M.; Peniche-Covas, C.; Domard, A. Biomacromolecules 2010, 11, 1376–1386. doi:10.1021/bm1001685 223.Einbu, A.; Grasdalen, H.; Vårum, K. M. Carbohydr. Res. 2007, 342, 1055–1062. doi:10.1016/j.carres.2007.02.022 224.Einbu, A.; Vårum, K. M. Biomacromolecules 2007, 8, 309–314. doi:10.1021/bm0608535
225.Vårum, K. Carbohydr. Polym. 2001, 46, 89–98. doi:10.1016/s0144-8617(00)00288-5 226.Tømmeraas, K.; Vårum, K. M.; Christensen, B. E.; Smidsrød, O. Carbohydr. Res. 2001, 333, 137–144. doi:10.1016/s0008-6215(01)00130-6 227.Defaye, J.; Gadelle, A.; Pedersen, C. Carbohydr. Res. 1994, 261, 267–277. doi:10.1016/0008-6215(94)84023-7 228.Capon, B.; Foster, R. L. J. Chem. Soc. C 1970, 1654–1655. doi:10.1039/j39700001654 229.Kidibule, P. E.; Santos-Moriano, P.; Jiménez-Ortega, E.; Ramírez-Escudero, M.; Limón, M. C.; Remacha, M.; Plou, F. J.; Sanz-Aparicio, J.; Fernández-Lobato, M. Microb. Cell Fact. 2018, 17, 47. doi:10.1186/s12934-018-0895-x 230.Vaaje-Kolstad, G.; Horn, S. J.; Sørlie, M.; Eijsink, V. G. H. FEBS J. 2013, 280, 3028–3049. doi:10.1111/febs.12181 231.Horn, S. J.; Sorbotten, A.; Synstad, B.; Sikorski, P.; Sorlie, M.; Varum, K. M.; Eijsink, V. G. H. FEBS J. 2006, 273, 491–503. doi:10.1111/j.1742-4658.2005.05079.x 232.Aam, B. B.; Heggset, E. B.; Norberg, A. L.; Sørlie, M.; Vårum, K. M.; Eijsink, V. G. H. Mar. Drugs 2010, 8, 1482–1517. doi:10.3390/md8051482


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2021
233.Nishimura, S.-I.; Kuzuhara, H.; Takiguchi, Y.; Shimahara, K. Carbohydr. Res. 1989, 194, 223–231. doi:10.1016/0008-6215(89)85021-9 234.Inaba, T.; OhgushiI, T.; Iga, Y.; Hasegawa, E. Chem. Pharm. Bull. 1984, 32, 1597–1603. doi:10.1248/cpb.32.1597 235.Barker, S. A.; Foster, A. B.; Stacey, M.; Webber, J. M. J. Chem. Soc. 1958, 2218–2227. doi:10.1039/jr9580002218 236.Despras, G.; Alix, A.; Urban, D.; Vauzeilles, B.; Beau, J.-M. Angew. Chem., Int. Ed. 2014, 53, 11912–11916. doi:10.1002/anie.201406802 237.Alsina, C.; Faijes, M.; Planas, A. Carbohydr. Res. 2019, 478, 1–9. doi:10.1016/j.carres.2019.04.001 238.Makino, A.; Ohmae, M.; Kobayashi, S. Macromol. Biosci. 2006, 6, 862–872. doi:10.1002/mabi.200600128 239.Sakamoto, J.; Sugiyama, J.; Kimura, S.; Imai, T.; Itoh, T.; Watanabe, T.; Kobayashi, S. Macromolecules 2000, 33, 4155–4160. doi:10.1021/ma000230y 240.Hashimoto, H.; Abe, Y.; Horito, S.; Yoshimura, J. J. Carbohydr. Chem. 1989, 8, 307–311. doi:10.1080/07328308908048012 241.Crout, D. H. G.; Vic, G. Curr. Opin. Chem. Biol. 1998, 2, 98–111. doi:10.1016/s1367-5931(98)80041-0 242.Singh, S.; Gallagher, R.; Derrick, P. J.; Crout, D. H. G. Tetrahedron: Asymmetry 1995, 6, 2803–2810. doi:10.1016/0957-4166(95)00370-5 243.Akiyama, K.; Kawazu, K.; Kobayashi, A. Carbohydr. Res. 1995, 279, 151–160. doi:10.1016/0008-6215(95)00288-x 244.Purushotham, P.; Podile, A. R. J. Bacteriol. 2012, 194, 4260–4271. doi:10.1128/jb.06473-11 245.Madhuprakash, J.; Tanneeru, K.; Purushotham, P.; Guruprasad, L.; Podile, A. R. J. Biol. Chem. 2012, 287, 44619–44627. doi:10.1074/jbc.m112.400879 246.Usui, T.; Matsui, H.; Isobe, K. Carbohydr. Res. 1990, 203, 65–77. doi:10.1016/0008-6215(90)80046-6 247.Ohnuma, T.; Tanaka, T.; Urasaki, A.; Dozen, S.; Fukamizo, T. J. Biochem. 2019, 165, 497–503. doi:10.1093/jb/mvy123 248.Sirimontree, P.; Suginta, W.; Sritho, N.; Kanda, Y.; Shinya, S.;
Ohnuma, T.; Fukamizo, T. Biosci., Biotechnol., Biochem. 2014, 78, 2014–2021. doi:10.1080/09168451.2014.948373 249.Ohnuma, T.; Fukuda, T.; Dozen, S.; Honda, Y.; Kitaoka, M.; Fukamizo, T. Biochem. J. 2012, 444, 437–443. doi:10.1042/bj20120036 250.Kohri, M.; Kobayashi, A.; Noguchi, M.; Kawaida, S.-i.; Watanabe, T.; Shoda, S.-i. Holzforschung 2006, 60, 485–491. doi:10.1515/hf.2006.080 251.Crich, D.; Dudkin, V. J. Am. Chem. Soc. 2001, 123, 6819–6825. doi:10.1021/ja010086b 252.Kuyama, H.; Nakahara, Y.; Nukada, T.; Ito, Y.; Nakahara, Y.; Ogawa, T. Carbohydr. Res. 1993, 243, C1–C7. doi:10.1016/0008-6215(93)84095-n 253.Kanie, O.; Ito, Y.; Ogawa, T. J. Am. Chem. Soc. 1994, 116, 12073–12074. doi:10.1021/ja00105a066 254.Yudina, O. N.; Tsvetkov, Y. E.; Nifantiev, N. E. Russ. Chem. Bull. 2015, 64, 2932–2941. doi:10.1007/s11172-015-1250-6 255.Yudina, O. N.; Tsvetkov, Y. E.; Nifantiev, N. E. Russ. Chem. Bull. 2016, 65, 2937–2942. doi:10.1007/s11172-016-1681-8 256.Kawada, T.; Yoneda, Y. Monatsh. Chem. 2009, 140, 1245–1250. doi:10.1007/s00706-009-0172-0 257.Kawada, T.; Yoneda, Y. Monatsh. Chem. 2009, 140, 1251–1256. doi:10.1007/s00706-009-0174-y
258.Bedini, E.; Cirillo, L.; Marchetti, R.; Basso, S.; Tufano, D.; Molinaro, A.; Parrilli, M. Synlett 2013, 25, 365–370. doi:10.1055/s-0033-1340323 259.Barroca-Aubry, N.; Pernet-Poil-Chevrier, A.; Domard, A.; Trombotto, S. Carbohydr. Res. 2010, 345, 1685–1697. doi:10.1016/j.carres.2010.05.010 260.Tyrikos‐Ergas, T.; Bordoni, V.; Fittolani, G.; Chaube, M. A.; Grafmüller, A.; Seeberger, P. H.; Delbianco, M. Chem. – Eur. J. 2021, 27, 2321–2325. doi:10.1002/chem.202005228 261.Enugala, R.; Carvalho, L. C. R.; Dias Pires, M. J.; Marques, M. M. B. Chem. – Asian J. 2012, 7, 2482–2501. doi:10.1002/asia.201200338 262.Yang, F.; Du, Y. Carbohydr. Res. 2003, 338, 495–502. doi:10.1016/s0008-6215(02)00494-9 263.Yamago, S.; Yamada, T.; Maruyama, T.; Yoshida, J.-i. Angew. Chem., Int. Ed. 2004, 43, 2145–2148. doi:10.1002/anie.200353552 264.Gening, M. L.; Tsvetkov, Y. E.; Pier, G. B.; Nifantiev, N. E. Carbohydr. Res. 2007, 342, 567–575. doi:10.1016/j.carres.2006.08.010 265.Gening, M. L.; Titov, D. V.; Grachev, A. A.; Gerbst, A. G.; Yudina, O. N.; Shashkov, A. S.; Chizhov, A. O.; Tsvetkov, Y. E.; Nifantiev, N. E. Eur. J. Org. Chem. 2010, 2465–2475. doi:10.1002/ejoc.200901275 266.Nokami, T.; Hayashi, R.; Saigusa, Y.; Shimizu, A.; Liu, C.-Y.; Mong, K.-K. T.; Yoshida, J.-i. Org. Lett. 2013, 15, 4520–4523. doi:10.1021/ol402034g 267.Kröck, L.; Esposito, D.; Castagner, B.; Wang, C.-C.; Bindschädler, P.; Seeberger, P. H. Chem. Sci. 2012, 3, 1617–1622. doi:10.1039/c2sc00940d 268.Morando, M.; Yao, Y.; Martín-Santamaría, S.; Zhu, Z.; Xu, T.; Cañada, F. J.; Zhang, Y.; Jiménez-Barbero, J. Chem. – Eur. J. 2010, 16, 4239–4249. doi:10.1002/chem.200902860 269.Hölemann, A.; Stocker, B. L.; Seeberger, P. H. J. Org. Chem. 2006, 71, 8071–8088. doi:10.1021/jo061233x 270.Cai, F.; Wu, B.; Crich, D. Stereocontrolled Synthesis of Mannans and Rhamnans. Advances in Carbohydrate Chemistry and Biochemistry; Elsevier: Amsterdam, Netherlands, 2009; pp 251–309. doi:10.1016/s0065-2318(09)00006-7 271.Cheon, H.-S.; Lian, Y.; Kishi, Y. Org. Lett. 2007, 9, 3323–3326. doi:10.1021/ol0713335 272.Li, X.; Li, C.; Liu, R.; Wang, J.; Wang, Z.; Chen, Y.; Yang, Y. Org. Lett. 2019, 21, 9693–9698. doi:10.1021/acs.orglett.9b03851 273.Jayaprakash, K. N.; Lu, J.; Fraser-Reid, B. Angew. Chem. 2005, 117, 6044–6048. doi:10.1002/ange.200500505 274.Sawettanai, N.; Leelayuwapan, H.; Karoonuthaisiri, N.; Ruchirawat, S.; Boonyarattanakalin, S. J. Org. Chem. 2019, 84, 7606–7617. doi:10.1021/acs.joc.8b02944 275.Leelayuwapan, H.; Kangwanrangsan, N.; Chawengkirttikul, R.; Ponpuak, M.; Charlermroj, R.; Boonyarattanakalin, K.; Ruchirawat, S.; Boonyarattanakalin, S. J. Org. Chem. 2017, 82, 7190–7199. doi:10.1021/acs.joc.7b00703 276.Calin, O.; Eller, S.; Seeberger, P. H. Angew. Chem., Int. Ed. 2013, 52, 5862–5865. doi:10.1002/anie.201210176 277.Naresh, K.; Schumacher, F.; Hahm, H. S.; Seeberger, P. H. Chem. Commun. 2017, 53, 9085–9088. doi:10.1039/c7cc04380e 278.Joseph, A. A.; Pardo-Vargas, A.; Seeberger, P. H. J. Am. Chem. Soc. 2020, 142, 8561–8564. doi:10.1021/jacs.0c00751 279.Yu, Y.; Kononov, A.; Delbianco, M.; Seeberger, P. H. Chem. – Eur. J. 2018, 24, 6075–6078. doi:10.1002/chem.201801023


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2022
280.Sahloul, K.; Lowary, T. L. J. Org. Chem. 2015, 80, 11417–11434. doi:10.1021/acs.joc.5b02083 281.Pardo-Vargas, A.; Bharate, P.; Delbianco, M.; Seeberger, P. H. Beilstein J. Org. Chem. 2019, 15, 2936–2940. doi:10.3762/bjoc.15.288 282.van der Vorm, S.; Hansen, T.; van Hengst, J. M. A.; Overkleeft, H. S.; van der Marel, G. A.; Codée, J. D. C. Chem. Soc. Rev. 2019, 48, 4688–4706. doi:10.1039/c8cs00369f 283.Nicolardi, S.; Joseph, A. A.; Zhu, Q.; Shen, Z.; Pardo-Vargas, A.; Chiodo, F.; Molinaro, A.; Silipo, A.; van der Burgt, Y. E. M.; Yu, B.; Seeberger, P. H.; Wuhrer, M. Anal. Chem. (Washington, DC, U. S.) 2021, 93, 4666–4675. doi:10.1021/acs.analchem.1c00239 284.Sasaki, K.; Tohda, K. Tetrahedron Lett. 2018, 59, 496–503. doi:10.1016/j.tetlet.2017.12.077 285.Li, Q.; Levi, S. M.; Jacobsen, E. N. J. Am. Chem. Soc. 2020, 142, 11865–11872. doi:10.1021/jacs.0c04255 286.Geng, X.; Wang, G.; Guo, Z.; Gu, G. J. Org. Chem. 2020, 85, 2369–2384. doi:10.1021/acs.joc.9b03085 287.Crich, D. Acc. Chem. Res. 2010, 43, 1144–1153. doi:10.1021/ar100035r 288.Crich, D.; Sun, S. Tetrahedron 1998, 54, 8321–8348. doi:10.1016/s0040-4020(98)00426-8 289.Crich, D.; Chandrasekera, N. S. Angew. Chem., Int. Ed. 2004, 43, 5386–5389. doi:10.1002/anie.200453688 290.Crich, D.; Banerjee, A.; Yao, Q. J. Am. Chem. Soc. 2004, 126, 14930–14934. doi:10.1021/ja047194t 291.Crich, D.; Li, W.; Li, H. J. Am. Chem. Soc. 2004, 126, 15081–15086. doi:10.1021/ja0471931 292.Crich, D.; Li, H.; Yao, Q.; Wink, D. J.; Sommer, R. D.; Rheingold, A. L. J. Am. Chem. Soc. 2001, 123, 5826–5828. doi:10.1021/ja015985e 293.Codée, J. D. C.; Kröck, L.; Castagner, B.; Seeberger, P. H. Chem. – Eur. J. 2008, 14, 3987–3994. doi:10.1002/chem.200701864 294.Ohara, K.; Lin, C.-C.; Yang, P.-J.; Hung, W.-T.; Yang, W.-B.; Cheng, T.-J. R.; Fang, J.-M.; Wong, C.-H. J. Org. Chem. 2013, 78, 6390–6411. doi:10.1021/jo4005266 295.Mathew, F.; Mach, M.; Hazen, K.; Fraser-Reid, B. Synlett 2003, 1319–1322. doi:10.1055/s-2003-40350 296.Nitz, M.; Purse, B. W.; Bundle, D. R. Org. Lett. 2000, 2, 2939–2942. doi:10.1021/ol0061743 297.Nitz, M.; Bundle, D. R. J. Org. Chem. 2001, 66, 8411–8423. doi:10.1021/jo010570x 298.van den Bos, L. J.; Dinkelaar, J.; Overkleeft, H. S.; van der Marel, G. A. J. Am. Chem. Soc. 2006, 128, 13066–13067. doi:10.1021/ja064787q 299.Codée, J. D. C.; van den Bos, L. J.; de Jong, A.-R.; Dinkelaar, J.; Lodder, G.; Overkleeft, H. S.; van der Marel, G. A. J. Org. Chem. 2009, 74, 38–47. doi:10.1021/jo8020192 300.Hansen, T.; Lebedel, L.; Remmerswaal, W. A.; van der Vorm, S.; Wander, D. P. A.; Somers, M.; Overkleeft, H. S.; Filippov, D. V.; Désiré, J.; Mingot, A.; Bleriot, Y.; van der Marel, G. A.; Thibaudeau, S.; Codée, J. D. C. ACS Cent. Sci. 2019, 5, 781–788. doi:10.1021/acscentsci.9b00042 301.Dinkelaar, J.; de Jong, A. R.; van Meer, R.; Somers, M.; Lodder, G.; Overkleeft, H. S.; Codée, J. D. C.; van der Marel, G. A. J. Org. Chem. 2009, 74, 4982–4991. doi:10.1021/jo900662v 302.Walvoort, M. T. C.; van den Elst, H.; Plante, O. J.; Kröck, L.; Seeberger, P. H.; Overkleeft, H. S.; van der Marel, G. A.;
Codée, J. D. C. Angew. Chem., Int. Ed. 2012, 51, 4393–4396. doi:10.1002/anie.201108744
303.Pan, D.; Zhang, L.; Hua, Q.; Yang, Y. Org. Biomol. Chem. 2019, 17, 6174–6177. doi:10.1039/c9ob01254k 304.Tang, S.-L.; Pohl, N. L. B. Org. Lett. 2015, 17, 2642–2645. doi:10.1021/acs.orglett.5b01013 305.Jahn, M.; Stoll, D.; Warren, R. A. J.; Szabó, L.; Singh, P.; Gilbert, H. J.; Ducros, V. M.-A.; Davies, G. J.; Withers, S. G. Chem. Commun. 2003, 1327–1329. doi:10.1039/b302380j 306.Grimaud, F.; Pizzut-Serin, S.; Tarquis, L.; Ladevèze, S.; Morel, S.; Putaux, J.-L.; Potocki-Veronese, G. Biomacromolecules 2019, 20, 846–853. doi:10.1021/acs.biomac.8b01457 307.Pawar, S. N.; Edgar, K. J. Biomaterials 2012, 33, 3279–3305. doi:10.1016/j.biomaterials.2012.01.007 308.Beswick, L.; Ahmadipour, S.; Dolan, J. P.; Rejzek, M.; Field, R. A.; Miller, G. J. Carbohydr. Res. 2019, 485, 107819. doi:10.1016/j.carres.2019.107819 309.Zhang, Q.; van Rijssel, E. R.; Overkleeft, H. S.; van der Marel, G. A.; Codée, J. D. C. Eur. J. Org. Chem. 2016, 2393–2397. doi:10.1002/ejoc.201600336 310.Dinkelaar, J.; van den Bos, L. J.; Hogendorf, W. F. J.; Lodder, G.; Overkleeft, H. S.; Codée, J. D. C.; van der Marel, G. A. Chem. – Eur. J. 2008, 14, 9400–9411. doi:10.1002/chem.200800960 311.Zhang, Q.; van Rijssel, E. R.; Walvoort, M. T. C.; Overkleeft, H. S.; van der Marel, G. A.; Codée, J. D. C. Angew. Chem., Int. Ed. 2015, 54, 7670–7673. doi:10.1002/anie.201502581 312.Giraud, M.-F.; Naismith, J. H. Curr. Opin. Struct. Biol. 2000, 10, 687–696. doi:10.1016/s0959-440x(00)00145-7 313.Geert Volbeda, A.; Reintjens, N. R. M.; Overkleeft, H. S.; van der Marel, G. A.; Codée, J. D. C. Eur. J. Org. Chem. 2016, 5282–5293. doi:10.1002/ejoc.201600956 314.Geert Volbeda, A.; van Mechelen, J.; Meeuwenoord, N.; Overkleeft, H. S.; van der Marel, G. A.; Codée, J. D. C. J. Org. Chem. 2017, 82, 12992–13002. doi:10.1021/acs.joc.7b02511 315.Tanaka, H.; Hamaya, Y.; Nishiwaki, N.; Ishida, H. Carbohydr. Res. 2018, 455, 23–31. doi:10.1016/j.carres.2017.11.005 316.Kohout, V. R.; Pohl, N. L. B. Carbohydr. Res. 2019, 486, 107829. doi:10.1016/j.carres.2019.107829 317.Zhang, J.; Kong, F. Tetrahedron 2003, 59, 1429–1441. doi:10.1016/s0040-4020(03)00075-9 318.Palmacci, E. R.; Plante, O. J.; Hewitt, M. C.; Seeberger, P. H. Helv. Chim. Acta 2003, 86, 3975–3990. doi:10.1002/hlca.200390331 319.Bedini, E.; Parrilli, M.; Unverzagt, C. Tetrahedron Lett. 2002, 43, 8879–8882. doi:10.1016/s0040-4039(02)02237-2 320.Bedini, E.; De Castro, C.; Erbs, G.; Mangoni, L.; Dow, J. M.; Newman, M.-A.; Parrilli, M.; Unverzagt, C. J. Am. Chem. Soc. 2005, 127, 2414–2416. doi:10.1021/ja0452166 321.Werz, D. B.; Seeberger, P. H. Angew. Chem., Int. Ed. 2005, 44, 6315–6318. doi:10.1002/anie.200502615 322.Govindarajan, M. Carbohydr. Res. 2020, 497, 108151. doi:10.1016/j.carres.2020.108151 323.Rai, D.; Kulkarni, S. S. Org. Biomol. Chem. 2020, 18, 3216–3228. doi:10.1039/d0ob00297f 324.Crich, D.; Bowers, A. A. Org. Lett. 2006, 8, 4327–4330. doi:10.1021/ol061706m 325.Zhu, Q.; Shen, Z.; Chiodo, F.; Nicolardi, S.; Molinaro, A.; Silipo, A.; Yu, B. Nat. Commun. 2020, 11, 4142. doi:10.1038/s41467-020-17992-x 326.Cai, J.; Hu, J.; Qin, C.; Li, L.; Shen, D.; Tian, G.; Zou, X.; Seeberger, P. H.; Yin, J. Angew. Chem., Int. Ed. 2020, 59, 20529–20537. doi:10.1002/anie.202007209


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2023
327.Yu, B. Acc. Chem. Res. 2018, 51, 507–516. doi:10.1021/acs.accounts.7b00573 328.Koeller, K. M.; Wong, C.-H. Chem. Rev. 2000, 100, 4465–4494. doi:10.1021/cr990297n
329.Pfrengle, F. Curr. Opin. Chem. Biol. 2017, 40, 145–151. doi:10.1016/j.cbpa.2017.09.010 330.Nepogodiev, S. A.; Field, R. A.; Damager, I. Approaches to Chemical Synthesis of Pectic Oligosaccharides. Annual Plant Reviews; Wiley-Blackwell: Oxford, UK, 2010; Vol. 41, pp 65–92. doi:10.1002/9781444391015.ch3 331.Lichtenthaler, F. W.; Oberthür, M.; Peters, S. Eur. J. Org. Chem. 2001, 3849–3869. doi:10.1002/1099-0690(200110)2001:20<3849::aid-ejoc3849>3.0.co;2 -q 332.Andersen, M. C. F.; Kračun, S. K.; Rydahl, M. G.; Willats, W. G. T.; Clausen, M. H. Chem. – Eur. J. 2016, 22, 11543–11548. doi:10.1002/chem.201602197 333.Andersen, M. C. F.; Boos, I.; Kinnaert, C.; Awan, S. I.; Pedersen, H. L.; Kračun, S. K.; Lanz, G.; Rydahl, M. G.; Kjærulff, L.; Håkansson, M.; Kimbung, R.; Logan, D. T.; Gotfredsen, C. H.; Willats, W. G. T.; Clausen, M. H. Org. Biomol. Chem. 2018, 16, 1157–1162. doi:10.1039/c7ob03035e 334.Bartetzko, M. P.; Schuhmacher, F.; Seeberger, P. H.; Pfrengle, F. J. Org. Chem. 2017, 82, 1842–1850. doi:10.1021/acs.joc.6b02745 335.Zeng, Y.; Li, A.; Kong, F. Tetrahedron Lett. 2003, 44, 8325–8329. doi:10.1016/j.tetlet.2003.08.087 336.Li, A.; Kong, F. Carbohydr. Res. 2004, 339, 1847–1856. doi:10.1016/j.carres.2004.05.007 337.Li, A.; Zeng, Y.; Kong, F. Carbohydr. Res. 2004, 339, 673–681. doi:10.1016/j.carres.2003.11.006 338.Li, A.; Kong, F. Bioorg. Med. Chem. 2005, 13, 839–853. doi:10.1016/j.bmc.2004.10.035 339.Andersen, M. C. F.; Boos, I.; Ruprecht, C.; Willats, W. G. T.; Pfrengle, F.; Clausen, M. H. J. Org. Chem. 2017, 82, 12066–12084. doi:10.1021/acs.joc.7b01796 340.Bartetzko, M. P.; Schuhmacher, F.; Hahm, H. S.; Seeberger, P. H.; Pfrengle, F. Org. Lett. 2015, 17, 4344–4347. doi:10.1021/acs.orglett.5b02185 341.Imamura, A.; Ando, H.; Korogi, S.; Tanabe, G.; Muraoka, O.; Ishida, H.; Kiso, M. Tetrahedron Lett. 2003, 44, 6725–6728. doi:10.1016/s0040-4039(03)01647-2 342.Imamura, A.; Matsuzawa, N.; Sakai, S.; Udagawa, T.; Nakashima, S.; Ando, H.; Ishida, H.; Kiso, M. J. Org. Chem. 2016, 81, 9086–9104. doi:10.1021/acs.joc.6b01685 343.Kazakova, E. D.; Yashunsky, D. V.; Krylov, V. B.; Bouchara, J.-P.; Cornet, M.; Valsecchi, I.; Fontaine, T.; Latgé, J.-P.; Nifantiev, N. E. J. Am. Chem. Soc. 2020, 142, 1175–1179. doi:10.1021/jacs.9b11703 344.Zhang, Y.; Gómez‐Redondo, M.; Jiménez‐Osés, G.; Arda, A.; Overkleeft, H. S.; Marel, G. A.; Jiménez‐Barbero, J.; Codée, J. D. C. Angew. Chem., Int. Ed. 2020, 59, 12746–12750. doi:10.1002/anie.202003951 345.Nakahara, Y.; Ogawa, T. Carbohydr. Res. 1989, 194, 95–114. doi:10.1016/0008-6215(89)85010-4 346.Nakahara, Y.; Ogawa, T. Carbohydr. Res. 1990, 205, 147–159. doi:10.1016/0008-6215(90)80135-p 347.Clausen, M. H.; Madsen, R. Chem. – Eur. J. 2003, 9, 3821–3832. doi:10.1002/chem.200204636 348.Clausen, M. H.; Jørgensen, M. R.; Thorsen, J.; Madsen, R. J. Chem. Soc., Perkin Trans. 1 2001, 543–551. doi:10.1039/b006981g
349.van den Bos, L. J.; Codée, J. D. C.; Litjens, R. E. J. N.; Dinkelaar, J.; Overkleeft, H. S.; van der Marel, G. A. Eur. J. Org. Chem. 2007, 3963–3976. doi:10.1002/ejoc.200700101 350.Justen, A. M.; Hodges, H. L.; Kim, L. M.; Sadecki, P. W.; Porfirio, S.; Ultee, E.; Black, I.; Chung, G. S.; Briegel, A.; Azadi, P.; Kiessling, L. L. Sci. Adv. 2020, 6, eaba4015. doi:10.1126/sciadv.aba4015 351.King, J. D.; Berry, S.; Clarke, B. R.; Morris, R. J.; Whitfield, C. Proc. Natl. Acad. Sci. U. S. A. 2014, 111, 6407–6412. doi:10.1073/pnas.1400814111 352.May, J. F.; Splain, R. A.; Brotschi, C.; Kiessling, L. L.
Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 11851–11856. doi:10.1073/pnas.0901407106 353.Wheatley, R. W.; Zheng, R. B.; Richards, M. R.; Lowary, T. L.; Ng, K. K. S. J. Biol. Chem. 2012, 287, 28132–28143. doi:10.1074/jbc.m112.347484 354.Savková, K.; Huszár, S.; Baráth, P.; Pakanová, Z.; Kozmon, S.; Vancová, M.; Tesařová, M.; Blaško, J.; Kaliňák, M.; Singh, V.; Korduláková, J.; Mikušová, K. Proc. Natl. Acad. Sci. U. S. A. 2021, 118, e2023663118. doi:10.1073/pnas.2023663118 355.Woodward, R.; Yi, W.; Li, L.; Zhao, G.; Eguchi, H.; Sridhar, P. R.; Guo, H.; Song, J. K.; Motari, E.; Cai, L.; Kelleher, P.; Liu, X.; Han, W.; Zhang, W.; Ding, Y.; Li, M.; Wang, P. G. Nat. Chem. Biol. 2010, 6, 418–423. doi:10.1038/nchembio.351 356.Peltier, P.; Euzen, R.; Daniellou, R.; Nugier-Chauvin, C.; Ferrières, V. Carbohydr. Res. 2008, 343, 1897–1923. doi:10.1016/j.carres.2008.02.010 357.Houseknecht, J. B.; Lowary, T. L. Curr. Opin. Chem. Biol. 2001, 5, 677–682. doi:10.1016/s1367-5931(01)00265-4 358.Completo, G. C.; Lowary, T. L. J. Org. Chem. 2008, 73, 4513–4525. doi:10.1021/jo800457j 359.Argunov, D. A.; Krylov, V. B.; Nifantiev, N. E. Org. Lett. 2016, 18, 5504–5507. doi:10.1021/acs.orglett.6b02735 360.Krylov, V. B.; Argunov, D. A.; Vinnitskiy, D. Z.; Verkhnyatskaya, S. A.; Gerbst, A. G.; Ustyuzhanina, N. E.; Dmitrenok, A. S.; Huebner, J.; Holst, O.; Siebert, H.-C.; Nifantiev, N. E. Chem. – Eur. J. 2014, 20, 16516–16522. doi:10.1002/chem.201405083 361.Joe, M.; Lowary, T. L. Can. J. Chem. 2016, 94, 976–988. doi:10.1139/cjc-2016-0416 362.Sabbavarapu, N. M.; Seeberger, P. H. J. Org. Chem. 2021, 86, 7280–7287. doi:10.1021/acs.joc.1c00505
363.Mourão, P. Trends Cardiovasc. Med. 1999, 9, 225–232. doi:10.1016/s1050-1738(00)00032-3 364.Berteau, O.; Mulloy, B. Glycobiology 2003, 13, 29R–40R. doi:10.1093/glycob/cwg058 365.Ustyuzhanina, N.; Krylov, V.; Grachev, A.; Gerbst, A.; Nifantiev, N. Synthesis 2006, 4017–4031. doi:10.1055/s-2006-950333 366.Arafuka, S.; Koshiba, N.; Takahashi, D.; Toshima, K. Chem. Commun. 2014, 50, 9831–9834. doi:10.1039/c4cc03544e 367.Liu, K.; Wang, L.; Guo, Z. J. Carbohydr. Chem. 2019, 38, 414–469. doi:10.1080/07328303.2019.1630841 368.Mishra, B.; Manmode, S.; Panda, R. R. A.; Hotha, S. Eur. J. Org. Chem. 2017, 4794–4802. doi:10.1002/ejoc.201700712 369.Podvalnyy, N. M.; Abronina, P. I.; Zdorovenko, E. L.; Chizhov, A. O.; Zinin, A. I.; Torgov, V. I.; Kononov, L. O. Russ. Chem. Bull. 2014, 63, 497–500. doi:10.1007/s11172-014-0459-0 370.Podvalnyy, N. M.; Chizhov, A. O.; Zinin, A. I.; Kononov, L. O. Carbohydr. Res. 2016, 431, 25–32. doi:10.1016/j.carres.2016.05.009 371.Leelayuwapan, H.; Ruchirawat, S.; Boonyarattanakalin, S. Carbohydr. Polym. 2019, 206, 262–272. doi:10.1016/j.carbpol.2018.10.048


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2024
372.Hori, M.; Nakatsubo, F. Macromolecules 2000, 33, 1148–1151. doi:10.1021/ma9915172 373.Panova, M. V.; Podvalnyy, N. M.; Okun, E. L.; Abronina, P. I.; Chizhov, A. O.; Kononov, L. O. Carbohydr. Res. 2018, 456, 35–44. doi:10.1016/j.carres.2017.11.002 374.Lu, J.; Fraser-Reid, B. Chem. Commun. 2005, 862–864. doi:10.1039/b413694b 375.Fraser-Reid, B.; Lu, J.; Jayaprakash, K. N.; López, J. C. Tetrahedron: Asymmetry 2006, 17, 2449–2463. doi:10.1016/j.tetasy.2006.09.008 376.Joe, M.; Bai, Y.; Nacario, R. C.; Lowary, T. L. J. Am. Chem. Soc. 2007, 129, 9885–9901. doi:10.1021/ja072892+ 377.Ishiwata, A.; Ito, Y. J. Am. Chem. Soc. 2011, 133, 2275–2291. doi:10.1021/ja109932t 378.Thadke, S. A.; Mishra, B.; Islam, M.; Pasari, S.; Manmode, S.; Rao, B. V.; Neralkar, M.; Shinde, G. P.; Walke, G.; Hotha, S. Nat. Commun. 2017, 8, 14019. doi:10.1038/ncomms14019 379.Islam, M.; Shinde, G. P.; Hotha, S. Chem. Sci. 2017, 8, 2033–2038. doi:10.1039/c6sc04866h 380.Pasari, S.; Manmode, S.; Walke, G.; Hotha, S. Chem. – Eur. J. 2018, 24, 1128–1139. doi:10.1002/chem.201704009 381.Kandasamy, J.; Hurevich, M.; Seeberger, P. H. Chem. Commun. 2013, 49, 4453–4455. doi:10.1039/c3cc00042g 382.Du, Y.; Pan, Q.; Kong, F. Synlett 1999, 1648–1650. doi:10.1055/s-1999-3170 383.Du, Y.; Pan, Q.; Kong, F. Carbohydr. Res. 2000, 329, 17–24. doi:10.1016/s0008-6215(00)00159-2 384.Ishiwata, A.; Akao, H.; Ito, Y. Org. Lett. 2006, 8, 5525–5528. doi:10.1021/ol062198j 385.Wu, Y.; Xiong, D.-C.; Chen, S.-C.; Wang, Y.-S.; Ye, X.-S. Nat. Commun. 2017, 8, 14851. doi:10.1038/ncomms14851 386.Mende, M.; Bednarek, C.; Wawryszyn, M.; Sauter, P.; Biskup, M. B.; Schepers, U.; Bräse, S. Chem. Rev. 2016, 116, 8193–8255. doi:10.1021/acs.chemrev.6b00010 387.Yu, M.; Zhang, T.; Zhang, W.; Sun, Q.; Li, H.; Li, J.-p. Front. Mol. Biosci. 2021, 7, 628551. doi:10.3389/fmolb.2020.628551 388.Zhang, Q.; Chen, C. Z.; Swaroop, M.; Xu, M.; Wang, L.; Lee, J.; Wang, A. Q.; Pradhan, M.; Hagen, N.; Chen, L.; Shen, M.; Luo, Z.; Xu, X.; Xu, Y.; Huang, W.; Zheng, W.; Ye, Y. Cell Discovery 2020, 6, 80. doi:10.1038/s41421-020-00222-5 389.Ricard-Blum, S.; Lisacek, F. Glycoconjugate J. 2017, 34, 339–349. doi:10.1007/s10719-016-9747-2 390.Mattson, J. M.; Turcotte, R.; Zhang, Y. Biomech. Model. Mechanobiol. 2017, 16, 213–225. doi:10.1007/s10237-016-0811-4 391.Badri, A.; Williams, A.; Linhardt, R. J.; Koffas, M. A. G. Curr. Opin. Biotechnol. 2018, 53, 85–92. doi:10.1016/j.copbio.2017.12.018 392.Gama, C. I.; Tully, S. E.; Sotogaku, N.; Clark, P. M.; Rawat, M.; Vaidehi, N.; Goddard, W. A., III; Nishi, A.; Hsieh-Wilson, L. C. Nat. Chem. Biol. 2006, 2, 467–473. doi:10.1038/nchembio810 393.Habuchi, H.; Habuchi, O.; Kimata, K. Glycoconjugate J. 2004, 21, 47–52. doi:10.1023/b:glyc.0000043747.87325.5e 394.Zhang, X.; Pagadala, V.; Jester, H. M.; Lim, A. M.; Pham, T. Q.; Goulas, A. M. P.; Liu, J.; Linhardt, R. J. Chem. Sci. 2017, 8, 7932–7940. doi:10.1039/c7sc03541a 395.Wang, Z.; Hsieh, P.-H.; Xu, Y.; Thieker, D.; Chai, E. J. E.; Xie, S.; Cooley, B.; Woods, R. J.; Chi, L.; Liu, J. J. Am. Chem. Soc. 2017, 139, 5249–5256. doi:10.1021/jacs.7b01923 396.Arnold, K.; Liao, Y.-E.; Liu, J. Biomedicines 2020, 8, 503. doi:10.3390/biomedicines8110503
397.Lee, J.-C.; Lu, X.-A.; Kulkarni, S. S.; Wen, Y.-S.; Hung, S.-C. J. Am. Chem. Soc. 2004, 126, 476–477. doi:10.1021/ja038244h 398.Miller, R. L.; Guimond, S. E.; Schwörer, R.; Zubkova, O. V.; Tyler, P. C.; Xu, Y.; Liu, J.; Chopra, P.; Boons, G.-J.; Grabarics, M.; Manz, C.; Hofmann, J.; Karlsson, N. G.; Turnbull, J. E.; Struwe, W. B.; Pagel, K. Nat. Commun. 2020, 11, 1481. doi:10.1038/s41467-020-15284-y 399.Liu, J.; Linhardt, R. J. Nat. Prod. Rep. 2014, 31, 1676–1685. doi:10.1039/c4np00076e 400.Hu, Y.-P.; Lin, S.-Y.; Huang, C.-Y.; Zulueta, M. M. L.; Liu, J.-Y.; Chang, W.; Hung, S.-C. Nat. Chem. 2011, 3, 557–563. doi:10.1038/nchem.1073 401.Muñoz-García, J. C.; López-Prados, J.; Angulo, J.; Díaz-Contreras, I.; Reichardt, N.; de Paz, J. L.; Martín-Lomas, M.; Nieto, P. M. Chem. – Eur. J. 2012, 18, 16319–16331. doi:10.1002/chem.201202770 402.Dai, X.; Liu, W.; Zhou, Q.; Cheng, C.; Yang, C.; Wang, S.; Zhang, M.; Tang, P.; Song, H.; Zhang, D.; Qin, Y. J. Org. Chem. 2016, 81, 162–184. doi:10.1021/acs.joc.5b02468 403.Zong, C.; Venot, A.; Li, X.; Lu, W.; Xiao, W.; Wilkes, J.-S. L.; Salanga, C. L.; Handel, T. M.; Wang, L.; Wolfert, M. A.; Boons, G.-J. J. Am. Chem. Soc. 2017, 139, 9534–9543. doi:10.1021/jacs.7b01399 404.Dey, S.; Wong, C.-H. Chem. Sci. 2018, 9, 6685–6691. doi:10.1039/c8sc01743c 405.Pawar, N. J.; Wang, L.; Higo, T.; Bhattacharya, C.; Kancharla, P. K.; Zhang, F.; Baryal, K.; Huo, C.-X.; Liu, J.; Linhardt, R. J.; Huang, X.; Hsieh‐Wilson, L. C. Angew. Chem., Int. Ed. 2019, 58, 18577–18583. doi:10.1002/anie.201908805 406.Hansen, S. U.; Baráth, M.; Salameh, B. A. B.; Pritchard, R. G.; Stimpson, W. T.; Gardiner, J. M.; Jayson, G. C. Org. Lett. 2009, 11, 4528–4531. doi:10.1021/ol901723m 407.Hansen, S. U.; Miller, G. J.; Jayson, G. C.; Gardiner, J. M. Org. Lett. 2013, 15, 88–91. doi:10.1021/ol303112y 408.Hansen, S. U.; Miller, G. J.; Cole, C.; Rushton, G.; Avizienyte, E.; Jayson, G. C.; Gardiner, J. M. Nat. Commun. 2013, 4, 2016. doi:10.1038/ncomms3016 409.Hansen, S. U.; Miller, G. J.; Cliff, M. J.; Jayson, G. C.; Gardiner, J. M. Chem. Sci. 2015, 6, 6158–6164. doi:10.1039/c5sc02091c 410.Zhang, X.; Lin, L.; Huang, H.; Linhardt, R. J. Acc. Chem. Res. 2020, 53, 335–346. doi:10.1021/acs.accounts.9b00420 411.Xu, Y.; Masuko, S.; Takieddin, M.; Xu, H.; Liu, R.; Jing, J.; Mousa, S. A.; Linhardt, R. J.; Liu, J. Science 2011, 334, 498–501. doi:10.1126/science.1207478 412.Xu, Y.; Cai, C.; Chandarajoti, K.; Hsieh, P.-H.; Li, L.; Pham, T. Q.; Sparkenbaugh, E. M.; Sheng, J.; Key, N. S.; Pawlinski, R.; Harris, E. N.; Linhardt, R. J.; Liu, J. Nat. Chem. Biol. 2014, 10, 248–250. doi:10.1038/nchembio.1459 413.Zong, C.; Venot, A.; Dhamale, O.; Boons, G.-J. Org. Lett. 2013, 15, 342–345. doi:10.1021/ol303270v 414.Masuko, S.; Bera, S.; Green, D. E.; Weïwer, M.; Liu, J.; DeAngelis, P. L.; Linhardt, R. J. J. Org. Chem. 2012, 77, 1449–1456. doi:10.1021/jo202322k 415.Weïwer, M.; Sherwood, T.; Green, D. E.; Chen, M.; DeAngelis, P. L.; Liu, J.; Linhardt, R. J. J. Org. Chem. 2008, 73, 7631–7637. doi:10.1021/jo801409c 416.Li, J.-p.; Hagner-McWhirter, Å.; Kjellén, L.; Palgi, J.; Jalkanen, M.; Lindahl, U. J. Biol. Chem. 1997, 272, 28158–28163. doi:10.1074/jbc.272.44.28158 417.Sheng, J.; Xu, Y.; Dulaney, S. B.; Huang, X.; Liu, J. J. Biol. Chem. 2012, 287, 20996–21002. doi:10.1074/jbc.m112.359885


Beilstein J. Org. Chem. 2021, 17, 1981–2025.
2025
418.Xu, Y.; Pempe, E. H.; Liu, J. J. Biol. Chem. 2012, 287, 29054–29061. doi:10.1074/jbc.m112.358523 419.Lu, W.; Zong, C.; Chopra, P.; Pepi, L. E.; Xu, Y.; Amster, I. J.; Liu, J.; Boons, G.-J. Angew. Chem., Int. Ed. 2018, 57, 5340–5344. doi:10.1002/anie.201800387
420.Yamada, S.; Sugahara, K. Curr. Drug Discovery Technol. 2008, 5, 289–301. doi:10.2174/157016308786733564 421.Ramadan, S.; Li, T.; Yang, W.; Zhang, J.; Rashidijahanabad, Z.; Tan, Z.; Parameswaran, N.; Huang, X. ACS Cent. Sci. 2020, 6, 913–920. doi:10.1021/acscentsci.9b01199 422.Li, J.; Su, G.; Liu, J. Angew. Chem., Int. Ed. 2017, 56, 11784–11787. doi:10.1002/anie.201705638 423.Sugiura, N.; Shimokata, S.; Minamisawa, T.; Hirabayashi, J.; Kimata, K.; Watanabe, H. Glycoconjugate J. 2008, 25, 521–530. doi:10.1007/s10719-008-9105-0 424.Köwitsch, A.; Zhou, G.; Groth, T. J. Tissue Eng. Regener. Med. 2018, 12, e23–e41. doi:10.1002/term.2398 425.Lu, X.; Kamat, M. N.; Huang, L.; Huang, X. J. Org. Chem. 2009, 74, 7608–7617. doi:10.1021/jo9016925 426.Walvoort, M. T. C.; Volbeda, A. G.; Reintjens, N. R. M.; van den Elst, H.; Plante, O. J.; Overkleeft, H. S.; van der Marel, G. A.; Codée, J. D. C. Org. Lett. 2012, 14, 3776–3779. doi:10.1021/ol301666n 427.Fu, X.; Shang, W.; Wang, S.; Liu, Y.; Qu, J.; Chen, X.; Wang, P. G.; Fang, J. Chem. Commun. 2017, 53, 3555–3558. doi:10.1039/c6cc09431g 428.Wang, Y.; Li, S.; Xu, X.; Tan, Y.; Liu, X.-w.; Fang, J. Carbohydr. Polym. 2020, 232, 115822. doi:10.1016/j.carbpol.2019.115822
429.Pomin, V. H. Int. J. Biol. Macromol. 2015, 72, 282–289. doi:10.1016/j.ijbiomac.2014.08.029 430.Ohmae, M.; Yamazaki, Y.; Sezukuri, K.; Takada, J.
Trends Glycosci. Glycotechnol. 2019, 31, E129–E136. doi:10.4052/tigg.1830.1e 431.Ohmae, M.; Sakaguchi, K.; Kaneto, T.; Fujikawa, S.-i.; Kobayashi, S. ChemBioChem 2007, 8, 1710–1720. doi:10.1002/cbic.200700252 432.Hahm, H. S.; Broecker, F.; Kawasaki, F.; Mietzsch, M.; Heilbronn, R.; Fukuda, M.; Seeberger, P. H. Chem 2017, 2, 114–124. doi:10.1016/j.chempr.2016.12.004 433.Kobayashi, Y.; Horie, Y.; Honjo, K.; Uemura, T.; Kitagawa, S. Chem. Commun. 2016, 52, 5156–5159. doi:10.1039/c6cc01357k 434.Holerca, M. N.; Peterca, M.; Partridge, B. E.; Xiao, Q.; Lligadas, G.; Monteiro, M. J.; Percec, V. J. Am. Chem. Soc. 2020, 142, 15265–15270. doi:10.1021/jacs.0c07912 435.Begum, S.; Hassan, Z.; Bräse, S.; Tsotsalas, M. Langmuir 2020, 36, 10657–10673. doi:10.1021/acs.langmuir.0c01832 436.Dawson, P. E.; Kent, S. B. H. Annu. Rev. Biochem. 2000, 69, 923–960. doi:10.1146/annurev.biochem.69.1.923 437.Kuir, D.; Guillemineau, M.; Auzanneau, F.-I. J. Org. Chem. 2015, 80, 5004–5013. doi:10.1021/acs.joc.5b00405 438.Lassfolk, R.; Rahkila, J.; Johansson, M. P.; Ekholm, F. S.; Wärnå, J.; Leino, R. J. Am. Chem. Soc. 2019, 141, 1646–1654. doi:10.1021/jacs.8b11563 439.Asano, S.; Tanaka, H.-N.; Imamura, A.; Ishida, H.; Ando, H. Org. Lett. 2019, 21, 4197–4200. doi:10.1021/acs.orglett.9b01372 440.El Seoud, O. A.; Koschella, A.; Fidale, L. C.; Dorn, S.; Heinze, T. Biomacromolecules 2007, 8, 2629–2647. doi:10.1021/bm070062i 441.Shi, X.; Huang, Y.; Mao, Y.; Naimy, H.; Zaia, J.
J. Am. Soc. Mass Spectrom. 2012, 23, 1498–1511. doi:10.1007/s13361-012-0429-4
442.Solleder, S. C.; Schneider, R. V.; Wetzel, K. S.; Boukis, A. C.; Meier, M. A. R. Macromol. Rapid Commun. 2017, 38, 1600711. doi:10.1002/marc.201600711 443.Aksakal, R.; Mertens, C.; Soete, M.; Badi, N.; Du Prez, F. Adv. Sci. 2021, 8, 2004038. doi:10.1002/advs.202004038 444.Martens, S.; Van den Begin, J.; Madder, A.; Du Prez, F. E.; Espeel, P. J. Am. Chem. Soc. 2016, 138, 14182–14185. doi:10.1021/jacs.6b07120 445.Al Ouahabi, A.; Charles, L.; Lutz, J.-F. J. Am. Chem. Soc. 2015, 137, 5629–5635. doi:10.1021/jacs.5b02639 446.Genabeek, B.; Lamers, B. A. G.; Hawker, C. J.; Meijer, E. W.; Gutekunst, W. R.; Schmidt, B. V. K. J.
J. Polym. Sci. (Hoboken, NJ, U. S.) 2021, 59, 373–403. doi:10.1002/pol.20200862 447.Govindaraju, T.; Avinash, M. B. Nanoscale 2012, 4, 6102–6117. doi:10.1039/c2nr31167d
License and Terms
This is an Open Access article under the terms of the
Creative Commons Attribution License
(https://creativecommons.org/licenses/by/4.0). Please note
that the reuse, redistribution and reproduction in particular
requires that the author(s) and source are credited and that
individual graphics may be subject to special legal
provisions.
The license is subject to the Beilstein Journal of Organic
Chemistry terms and conditions:
(https://www.beilstein-journals.org/bjoc/terms)
The definitive version of this article is the electronic one
which can be found at:
https://doi.org/10.3762/bjoc.17.129